Top

Steven G. Waguespack, M.D.

Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine

About Dr. Waguespack

Dr. Steven Waguespack is a Professor of internal medicine and pediatrics at The University of Texas MD Anderson Cancer Center in Houston. A native of Louisiana, Dr. Waguespack graduated summa cum laude from Loyola University in New Orleans, where he also participated in the presidential scholars honor program. He graduated with honors, including junior induction into the Alpha Omega Alpha Honor Medical Society, from The University of Texas Medical School at Houston (now known as the John P. and Kathrine G. McGovern Medical School). Dr. Waguespack completed training in internal medicine/pediatrics followed by a combined adult and pediatric endocrinology fellowship at the Indiana University Medical Center in Indianapolis. He maintains board certification in both subspecialties. Consistently recognized as one of "America's Top Doctors for Cancer" in endocrinology, his major clinical and research interests are thyroid cancer, pituitary tumors, and hereditary syndromes of endocrine neoplasia. At MD Anderson, where he has been on faculty since 2002, Dr. Waguespack enjoys providing endocrine care to patients of all ages.

Meet Steven Waguespack, M.D.

In the News

Woman holding her forehead in pain and leans against a wall

6 things to know about pituitary adenomas

Illustration of a lump on the thyroid gland, which can be an early sign of cancer.

Common thyroid cancer symptoms to look for

View more View less

Present Title & Affiliation

Primary Appointment

Professor (Adjunct), Department of Pediatrics, Division of Pediatric Endocrinology, The University of Texas John P. and Kathrine G. McGovern Medical School at Houston, Houston, TX

Professor, Department of Pediatrics-Patient Care, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX

Professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Professor (Adjunct), Department of Pediatrics, The University of Texas John P. and Kathrine G. McGovern Medical School at Houston, Houston, TX

Professor, Department of Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX

Professor, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX

Research Interests

Thyroid Cancer, Pituitary Tumors, Hereditary Endocrine Neoplasia Syndromes (MEN1, MEN2, VHL, familial paraganglioma syndromes), and Pediatric Endocrine Tumors

For a full list of Dr. Waguespack's publications, please copy and paste the following link into your browser:

https://www.ncbi.nlm.nih.gov/myncbi/steven.waguespack.2/bibliography/public/

Clinical Interests

Thyroid Cancer, Pituitary Tumors, Hereditary Endocrine Neoplasia Syndromes (MEN1, MEN2, VHL, familial paraganglioma syndromes), and Pediatric Endocrine Tumors

For general clinic information and referrals, please visit the Department of Endocrine Neoplasia and Hormonal Disorders' contact information webpage at:

Contact Information

Education & Training

Degree-Granting Education

1994	The University of Texas Medical School at Houston (now known as the John P. and Kathrine G. McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth)), Houston, Texas, US, MD
1990	Loyola University, New Orleans, Louisiana, US, Biology, BS

Postgraduate Training

1998-2002	Fellowship, Adult and Pediatric Endocrinology, Indiana University Medical Center, Indianapolis, Indiana
1994-1998	Internship and Residency, Internal Medicine/ Pediatrics, Indiana University Medical Center, Indianapolis, Indiana

Licenses & Certifications

2024	Alabama Board of Medical Examiners
2023	Mississippi State Board of Medical Licensure
2023	Georgia Composite Medical Board
2023	Oklahoma State Board of Medical Licensure
2023	Tennessee Board of Medical Examiners
2023	Arizona Board of Medical Examiners
2023	Louisiana State Board of Medical Examiners
2023	Washington State Department of Health
2021	Florida Board of Medicine
2003	Pediatric Endocrinology
2002	Texas Medical Board
2002	Endocrinology, Diabetes, and Metabolism
1999	General Pediatrics
1998	Internal Medicine

Experience & Service

Faculty Academic Appointments

Associate Professor (Adjunct), Department of Pediatrics, The University of Texas John P. and Kathrine G. McGovern Medical School at Houston, Houston, TX, 2012 - 2018

Associate Professor, Department of Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2012

Associate Professor, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2012

Assistant Professor, Department of Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, 2002 - 2007

Assistant Professor, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2002 - 2007

Chief Resident (Med-Peds), Department of Internal Medicine and Pediatrics, Indiana University Medical Center, Indianapolis, IN, 1997 - 1998

Administrative Appointments/Responsibilities

Deputy Department Chair, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2015

Rotation Program Coordinator, Department of Endocrinology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - 2008

Other Professional Positions

Consultant, Pediatric Oncology Branch, National Cancer Institute, National Institute of Health, Bethesda, MD, 2020

Consultant, Pediatric Oncology Branch, National Cancer Institute, National Institute of Health, Bethesda, MD, 2018

Member, NCCN Thyroid Carcinoma Panel, N/A, 2007 - 2014

Facilitator, Endocrine Fellows' Core Curriculum Conference, Houston, TX, 2005 - 2008

Facilitator, Endocrine Neoplasia Multidisciplinary Conference, Houston, TX, 2003 - 2009

Staff Physician, St. Francis Hospitals, Indianapolis, IN, 2000 - 2002

Staff Physician, Bellflower Clinic, Indianapolis, IN, 1997 - 2001

ER Physician, Wishard Memorial Hospital, Indianapolis, IN, 1997 - 1998

Physician member, Transport Team, Riley Children's Hospital, Indianapolis, IN, 1995 - 2000

Teaching Assistant and Tutor, University of Texas Medical School at Houston, Houston, TX, 1991 - 1992

Participant, Summer Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, 1991

Intramural Institutional Committee Activities

Chair, Clinical Faculty Review Committee, The University of Texas MD Anderson Cancer Center, 2025 - 2026

Vice Chair, Clinical Faculty Review Committee, The University of Texas MD Anderson Cancer Center, 2024 - 2025

Member, Clinical Faculty Review Committee, The University of Texas MD Anderson Cancer Center, 2023 - 2024

Extramural Institutional Committee Activities

Member (elected position), PRS Retirement Board, The University of Texas MD Anderson Cancer Center, 2021 - 2023

Member, Review Board for the DoIM Faculty Excellence Awards in Patient Care, The University of Texas MD Anderson Cancer Center, 2018

Member (elected position), PRS Faculty Compensation and Benefit Advisory Committee, The University of Texas MD Anderson Cancer Center, 2017 - 2021

Member, CFA Service Excellence Working Group, The University of Texas MD Anderson Cancer Center, 2016 - 2016

Member, Search Committee for Physician Scientist Faculty Position, The University of Texas MD Anderson Cancer Center, 2015

Member, Mid-Cycle Review for Dr. Khanh Vu, The University of Texas MD Anderson Cancer Center, 2015

Chair, Mid-Cycle Review Panel for Dr. John Patlan, The University of Texas MD Anderson Cancer Center, 2014 - 2014

Member, Clinical Faculty Review Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2017

Departmental representative, Faculty Appeals Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2022

Member, Executive Billing Compliance Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2020

Member, MD Anderson Physicians Network Board of Directors, The University of Texas MD Anderson Cancer Center, 2012 - 2015

departmental representative, Provider Ambassador Program (for ICD10 rollout), The University of Texas MD Anderson Cancer Center, 2012 - 2015

Co-Chair, Endocrine Clinical Practice Committee, The University of Texas MD Anderson Cancer Center, 2011 - 2012

Member, Mid-Cycle Review Panel for Dr. Maria-Claudia Campagna, The University of Texas MD Anderson Cancer Center, 2010

Chair, Mid-Cycle Review Panel for Dr. Mimi Hu, The University of Texas MD Anderson Cancer Center, 2010 - 2010

Member, Clinical Effectiveness Focus Group, The University of Texas MD Anderson Cancer Center, 2010

Physician lead, Standard References for Algorithms Task Force (of the CSE subcommittee), The University of Texas MD Anderson Cancer Center, 2009 - 2009

Member, Mid-Cycle Review Panel for Dr. Demetrios Petropoulos, The University of Texas MD Anderson Cancer Center, 2009 - 2009

Member, CCH Physician Referral Advisory Group, The University of Texas MD Anderson Cancer Center, 2009 - 2010

Member, Thyroid Cancer Survivorship Oversight Committee, The University of Texas MD Anderson Cancer Center, 2008

Member, Clinical Effectiveness Subcommittee (of the Executive Committee of the Medical Staff), The University of Texas MD Anderson Cancer Center, 2007 - 2010

Member, Credentials Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2007 - 2010

Member, Cancer Survivorship Focus Group, The University of Texas MD Anderson Cancer Center, 2007

Member, Division of Internal Medicine Quality Council, The University of Texas MD Anderson Cancer Center, 2007 - 2008

Member, Endocrine Neoplasia & Hormonal Disorders Newsletter and Website Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2014

Member, Pediatric Survivorship Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2008

Member, Electronic Medical Record Physician Working Group, The University of Texas MD Anderson Cancer Center, 2006 - 2007

Member, Search Committee for Diabetes Faculty Position, The University of Texas MD Anderson Cancer Center, 2005

Member, Graduate Medical Education Committee, Budget Subcommittee, The University of Texas MD Anderson Cancer Center, 2005 - 2008

Member, Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 2005 - 2008

Member, Adolescent and Young Adult Program Task Force, The University of Texas MD Anderson Cancer Center, 2004

Editorial Activities

Editorial Board, JCEM Case Reports, 2022 - 2025

Editorial Board, Thyroid, 2010 - 2016

Honors & Awards

2025	Top 1 Percentile Performer
2024	Top 1 Percentile Performer
2023	Castle Connolly Top Doctor of Houston
2022 - 2023	Texas Super Doctor
2021 - 2022	Top Performer Recognition (Scored in the top 10% nationally on Consumer Assessment of Healthcare Providers and Systems surveys)
2018	Top 1 Percentile Performer
2017 - 2019	Top Performer Recognition (Scored in the top 1% nationally on Consumer Assessment of Healthcare Providers and Systems surveys)
2017	APRN Fellows' Choice Award: Outstanding Faculty Preceptor 2017, Department of Nursing, University of Texas MD Anderson Cancer Center
2016	Faculty Excellence in Patient Care Award, Division of Internal Medicine, MD Anderson Cancer Center
2013	Division of Internal Medicine Clinical Leadership Award, University of Texas MD Anderson Cancer Center
2010	Faculty Educator of the Month August 2010, University of Texas MD Anderson Cancer Center
2010	Top Endocrinologist in "The Leading Physicians of the World", International Association of Healthcare Professionals
2010 - 2012	Patients' Choice Award
2010	Compassionate Doctor Recognition
2009 - 2026	Castle Connolly America's Top Doctors in Endocrinology, Diabetes, and Metabolism
2007	Recognized as an excellent CRC protocol reviewer
2007 - 2016	Best Doctors in America, Best Doctors, Inc
2007 - 2013	Multi-Year Appointment Award
2007 - 2010	America's Top Pediatricians, Consumers' Research Council of America
2007	Division of Internal Medicine Cyrus Scholar Award Semifinalist, University of Texas, MD Anderson Cancer Center
2005 - 2014	Castle Connolly America's Top Doctors for Cancer
2005	Fellow, American Academy of Pediatrics
2005	Fellow, American College of Endocrinology
2005	Teacher of the Year (Awarded by graduating endocrine fellows)
2002	1st place, 6th Annual Research Competition, "Characterization of Mutations in the Chloride Channel 7 (CICN7) Gene That Cause Autosomal Dominant Osteopetrosis, Type II", Indiana University Department of Medicine
2002	Clinical Fellows Travel Grant Award to attend the 84th Meeting of the Endocrine Society, Genentech
2002	Richard B. Schnute Award in recognition of outstanding compassion, professionalism, and clinical care as exemplified by Dr. Schnute, Indiana University School of Medicine
2001	2nd place, 5th Annual Research Competition, "Measurement of Tartrate-Resistant Acid Phosphatase (TRAP) and the brain Isoenzyme of Creatine Kinase (CK-BB) Accurately Diagnoses Type II Autosomal Dominant Osteopetrosis but Does Not Identify Gene Carriers", Indiana University Department of Medicine
2001	ESPE Summer School, One of 15 North American fellows selected by the LWPES to attend the ESPE Summer School in Quebec, Canada
2001	Travel Grant Award, One of 5 American fellows chosen by the LWPES to attend the “Advanced Postgraduate Course on Growth and Growth Disorders” in Stockholm, Sweden
2000 - 2001	National Research Service Award
1999	Endocrine Fellows Foundation Grant
1994	Annual Award for Excellence in Pediatrics, University of Texas Medical School at Houston
1994	Walter G. Sterling Award for Excellence, University of Texas Medical School at Houston
1993	Alpha Omega Alpha induction as a junior medical student, University of Texas Medical School at Houston
1992	Academic achievement award, Medical Pharmacology and Neuroscience, University of Texas Medical School at Houston
1992	Student Book Award for highest total number of honors grades, University of Texas Medical School at Houston
1990 - 1994	Academic Scholarship, University of Texas Medical School at Houston
1990	The Ruth & Lee Faust Award for outstanding academic achievement by a graduate in biological sciences, Loyola University
1986 - 1990	Presidential Scholarship Honors Program (full academic scholarship), Loyola University

Professional Memberships

International Thyroid Oncology Group

2025 - Present

ENS@T-European Network for the Study of Adrenal Tumors

2024 - Present

NANETS-North American Neuroendocrine Tumor Society

2023 - Present

Association for Multiple Endocrine Neoplasia Disorders (AMEND) USA

2021 - Present

NTRKers (NTRK Patient Community)

2020 - Present

VHL Alliance

2019 - Present

Child and Adolescent Thyroid Consortium (CATC)

2018 - Present

ThyCa: Thyroid Cancer Survivors' Association, Inc

2010 - Present

American Thyroid Association

2008 - Present

National Cancer Comprehensive Network

2007 - 2014

Harris County Medical Society

2007 - Present

American Association of Clinical Endocrinologists

2002 - 2024

Pediatric Endocrine Society (formerly known as the Lawson Wilkins Pediatric Endocrine Society)

1999 - Present

The Endocrine Society

1999 - Present

Alpha Omega Alpha Honor Medical Society

1993 - Present

Alpha Sigma Nu National Honor Society

1990 - Present

Selected Presentations & Talks

Local Presentations

2023. TRK Fusion Thyroid Cancer—What do We Know in 2023?. Invited. University of Texas MD Anderson Cancer Center. Houston, TX, US.
2019. Treatment of Pheochromocytoma/Paraganglioma in Children and Adolescents. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2018. Thyroid Cancer in the Adolescent/Young Adult. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2018. Overview of Pediatric ATA Guidelines. Conference. International Pediatric Thyroid Cancer Conference. Houston, TX, US.
2018. Treatment of Pheo/Para in Children and Adolescents. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2017. Pediatric Differentiated Thyroid Cancer. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2015. Pediatric Thyroid Cancer: New Guidelines for Care and Treatment of Advanced Disease. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2015. Pediatric Differentiated Thyroid Cancer. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
2013. Clinical Pathologic Conference: A Woman with Breast Cancer and Type 2 Diabetes Mellitus. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2013. Genetics, Screening, Evaluation, and Treatment of Medullary Thyroid Cancer. Conference. 5th Current Concepts in the Management of Thyroid and Parathyroid Neoplasms. Houston, TX, US.
2011. Late Effects of Childhood Cancer: The Patient’s Journey Continues. Conference. Colloquim Panel on Developing Strategies for Reducing Cancer Treatment-Related Toxicities and Symptoms. Houston, TX, US.
2011. Genetic and Oncologic Syndromes of the Adrenal Gland: When the Zebra Makes the Hoofbeats. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
2009. Endocrine Tumors. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
2009. Hypercalcemia and Hypocalcemia. Conference. University of Texas, MD Anderson Cancer Center. Houston, TX, US.
2008. Clinical Pathological Conference: Pheochromocytoma. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
2008. The Use of Targeted Therapy in Pediatric Thyroid Cancer: A Paradigm for Medical Progress in an Orphan Disease. Invited. University of Texas MD Anderson Cancer Center. Houston, TX, US.
2007. Care of the Pediatric Thyroid Cancer Patient. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
2006. Pediatric Osteoporosis. University of Texas MD Anderson Cancer Center. Houston, TX, US.
2005. Diabetes in Children and Adolescents: An Update", Diabetes Management Da. Conference. University of Texas, MD Anderson Cancer Center. Houston, TX, US.
2005. Update on Acromegaly. Conference. University of Texas, MD Anderson Cancer Center. Houston, TX, US.
2004. Pediatric Thyroid Cancer. Conference. University of Texas, MD Anderson Cancer Center. Houston, TX, US.
2004. Pediatric Osteoporosis. Conference. Pediatric Endocrinology Nurses regional meeting. Houston, TX, US.
2003. Adrenal Meet-the-Professor Session. Conference. University of Texas, MD Anderson Cancer Center. Houston, TX, US.

Regional Presentations

2025. Prolactinoma (Keynote Speaker). Invited. Neuroendocrine Hybrid Symposium IV. Philadelphia, Pennsylvania, US.
2025. Developments in thyroid cancer systemic therapy for all ages?. Invited. THYROID CANCER BEYOND BORDERS: Answers to Questions. Groningen, NL.
2025. Updates on ATA Guidelines. Invited. 10th Annual Pediatric Thyroid Symposium. Seattle, Washington, US.
2025. Scott Manning Lecture: MEN2 State of the Art. Invited. 10th Annual Pediatric Thyroid Symposium. Seattle, Washington, US.
2023. Advanced Differentiated Thyroid Cancer: Management in the Era of Precision Medicine (keynote). Invited. The University of Kansas Cancer Center. Overland Park, Kansas, US.
2023. Treatment Implications of Genetic Testing Results for Hereditary Endocrine Predisposition Syndromes. Conference. University of Texas MD Anderson Cancer Center. Virtual Conference, TX, US.
2023. PPGL in Children: An Update on a PHEOnomenally Rare Disease. Conference. PESTOLA (Pediatric Endocrine Society of Texas, Oklahoma, Louisiana and Arkansas). Oklahoma City, OK, US.
2022. MEN1 and MEN2 in Children: An Update on Management. Conference. PESTOLA (Pediatric Endocrine Society of Texas, Oklahoma, Louisiana and Arkansas). Austin, TX, US.
2018. Hereditary Endocrine Tumor Syndromes: An Update. Conference. Philadelphia Endocrine Society. Philadelphia, PA, US.
2018. Update on the Genetics of Pediatric Endocrine Tumors. Conference. 8th Annual NYU Winthrop Pediatric Endocrinology Symposium. Mineola, NY, US.
2018. MTC and MEN2: Past, Present, and Future. Conference. Heartland Chapter American Association of Clinical Endocrinologists. Tulsa, OK, US.
2018. Advanced DTC Interactive Case Discussions. Conference. Heartland Chapter American Association of Clinical Endocrinologists. Tulsa, OK, US.
2016. Pediatric Thyroid Nodules and Differentiated Thyroid Cancer: Contemporary Guidelines for Management. Conference. Midwest Pediatric Endocrine Society. Chicago, IL, US.
2016. Hereditary Endocrine Cancer Syndromes. Conference. PESTOLA (Pediatric Endocrine Society of Texas, Oklahoma, Louisiana and Arkansas). Fort Worth, TX, US.
2015. Medullary Thyroid Cancer: Revised management guidelines and new treatment options. Conference. Texas Chapter of AACE (TX-AACE) Annual Meeting / Texas Endocrine Surgical Society (TESS) Surgical Symposium. Austin, TX, US.
2011. Current and Future Therapeutic Options for Acromegaly: A Case-Based Discussion. Conference. TX-AACE/TESS 2011 Annual Meeting & Surgical Symposium. Austin, TX, US.
2011. Pediatric Thyroid Nodules and Cancer: A Case-Based Review for the Pediatric Endocrinologist. Conference. PESTOLA (Pediatric Endocrine Society of Texas, Oklahoma, Louisiana and Arkansas). New Orleans, LA, US.
2010. Adrenal Tumors in Childhood: A Primer for the Pediatric Endocrinologist. Conference. 7th Annual Great Plains Pediatric Endocrine Symposium. Kansas City, MO, US.
2010. Pediatric Thyroid Nodules and Cancer: A Case-Based Review for the Pediatric Endocrinologist. Conference. 7th Annual Great Plains Pediatric Endocrine Symposium. Kansas City, MO, US.
2010. Recent Advances in the Diagnosis and Management of Pituitary Tumors. Conference. Southern States Chapter of the American Association of Clinical Endocrinologists 2010 Annual Meeting & Symposium. New Orleans, LA, US.
2009. Endocrine Tumors in Children: Approaches to Diagnosis and Management. Conference. Children’s Mercy Hospitals and Clinics. Kansas City, MO, US.
2007. Adrenal Tumors in Childhood: Diagnosis and Treatment. Conference. PESTOLA (Pediatric Endocrine Society of Texas, Oklahoma, Louisiana and Arkansas). San Antonio, TX, US.
2006. Interactive Cases with Audience Response, Adrenal Disease and MEN. Conference. Texas Endocrine Society. Galveston, TX, US.
2004. Pediatric Osteoporosis. Conference. PESTOLA (Pediatric Endocrine Society of Texas, Oklahoma, Louisiana and Arkansas). Dallas, TX, US.
2004. Genetic and Clinical Studies of Autosomal Dominant Osteopetrosis, Type 2. Conference. Endocrine Research Dinner, US.
2004. Update in Acromegaly. Conference. Texas Chapter of the American Association of Clinical Endocrinologists. Austin, TX, US.
2003. Endocrine Disorders and Langerhans Cell Histiocytosis. Conference. PESTOLA (Pediatric Endocrine Society of Texas, Oklahoma, Louisiana and Arkansas). Galveston, TX, US.
2002. Characterization of Mutations in the Chloride Channel 7 Gene That Cause Autosomal Dominant Osteopetrosis, Type II. Conference. Indiana University School of Medicine. Indianapolis, IN, US.
2002. Disorders of GH Excess. Conference. Indiana University School of Medicine. Indianapolis, IN, US.
2001. Genetic and Clinical Studies of Autosomal Dominant Osteopetrosis, Type II. Conference. Indiana University School of Medicine. Indianapolis, IN, US.
2001. Measurement of Tartrate-Resistant Acid Phosphatase (TRAP) and the Brain Isoenzyme of Creatine Kinase (CK-BB) Accurately Diagnoses Type II Autosomal Dominant Osteopetrosis but Does not Identify Gene Carriers. Conference. Indiana University School of Medicine. Indianapolis, IN, US.
2001. Genetic and Clinical Studies of Autosomal Dominant Osteopetrosis, Type II. Conference. Indiana University School of Medicine. Indianapolis, IN, US.
1999. Delayed Puberty. Conference. Indiana University School of Medicine. Indianapolis, IN, US.

National Presentations

2026. Multiple Endocrine Neoplasia Type 1. Invited. EFF Rare Endocrine Diseases ECHO for Fellows, US.
2025. TRK fusion-positive Thyroid Carcinoma: An Overview. Invited. American Thyroid Association Annual Meeting 2025. Scottsdale, Arizona, US.
2025. Clinicopathological Correlates of BRAF V600E-mutated Versus Wild-type Pediatric Papillary Thyroid Carcinoma. Poster. American Thyroid Association Annual Meeting 2025. Scottsdale, Arizona, US.
2025. Understanding Patient Treatment Decision-Making for Risk Reducing/Early Thyroidectomy in Hereditary Medullary Thyroid Cancer: A Discrete Choice Experiment. Poster. American Thyroid Association Annual Meeting 2025. Scottsdale, Arizona, US.
2025. Neoadjuvant Targeted Therapy for Locally Advanced Differentiated Thyroid Carcinoma (DTC). Invited. American Thyroid Association Annual Meeting 2025. Scottsdale, Arizona, US.
2025. "The Genomic Landscape of 250,000+ Thyroid Nodules Undergoing Exome-enriched RNA Sequencing”. Poster. American Thyroid Association Annual Meeting 2025. Scottsdale, Arizona, US.
2025. "The Genomic Landscape of Medullary Thyroid Carcinoma (MTC) Identified by the Afirma RNA-Sequencing Classifier: Insights from a Large Real-World Cohort". Poster. American Thyroid Association Annual Meeting 2025. Scottsdale, Arizona, US.
2025. "Outcomes of Brain Metastases from Medullary Thyroid Carcinoma: A Retrospective Cohort Study". Poster. American Thyroid Association Annual Meeting 2025. Scottsdale, Arizona, US.
2025. Safety and efficacy of second dose of AIC100 CAR T-cell in patients with poorly differentiated (PDTC) and anaplastic thyroid carcinoma (ATC). Poster. American Thyroid Association Annual Meeting 2025. Scottsdale, Arizona, US.
2025. Malignant Struma Ovarii Clinical Characteristics and Outcomes: A Retrospective Tertiary Cancer Center Experience. Invited. American Thyroid Association Annual Meeting 2025. Scottsdale, Arizona, US.
2025. Surgical management of isthmus-confined papillary thyroid carcinoma: a single institution retrospective cohort study. Poster. American Thyroid Association Annual Meeting 2025. Scottsdale, Arizona, US.
2025. Neoadjuvant Treatment With Selpercatinib for RET-Altered Thyroid Cancer: A Multicenter Phase 2 Clinical Trial. Invited. American Thyroid Association Annual Meeting 2025. Scottsdale, Arizona, US.
2025. Screening in MEN1 and SDHx Syndromes: Is it Really That Straightforward? (Spark session with Jaydira del Rivero, MD). Invited. Pediatric Endocrine Society 2025 Annual Meeting. National Harbor, Maryland, US.
2025. Polyglandular Autoimmune Disease, Hereditary Endocrine Tumor Syndromes and Some “Other Hormones”. Invited. PES 2025 Board Review Course. National Harbor, Maryland, US.
2025. Pediatric Thyroid Carcinoma. Panelist. TIROxMDS International Pediatric Tumor Board. Virtual, US.
2024. MEN1 and MEN2: Updates for the General Endocrinologist. Invited. Endocrine Grand Rounds. Virtual, US.
2024. Thyroid cancer risk and surveillance across hereditary polyposis syndromes. Invited. CGA-IGC 2024 Annual Meeting. Philadelphia, Pennsylvania, US.
2024. Medullary Thyroid Cancer Case Panel. Panelist. 2024 Ridgway Trainee Conference. Chicago, Illinois, US.
2024. Clinicopathologic Characteristics of Pediatric Follicular Variant of Papillary Thyroid Carcinoma Subtypes: A Retrospective Cohort Study (Invited Discussion). Invited. TIROxMDs Journal Club. Virtual, US.
2024. Real-Life Safety Monitoring for Patients with Advanced Thyroid Cancer on Targeted Therapy: A Quality Improvement Project. Invited. The Endocrine Society. Boston, MA, US.
2024. Clinical Outcomes of Thyroid Cancer Patients Enrolled in A Comprehensive Thyroid Cancer Survivorship Program. Invited. The Endocrine Society. Boston, MA, US.
2024. Updates in MTC and MEN2. Invited. Endocrine Fellow Conference. San Francisco, California, US.
2024. Treating Advanced Papillary Thyroid Carcinoma Across the Age Spectrum. Invited. Endocrine Grand Rounds. San Francisco, California, US.
2023. Clinical Characteristics of a Pediatric Papillary Thyroid Carcinoma Cohort with a Tumor. Invited. Pediatric Endocrine Society. Chicago, IL, US.
2023. Arthur Bauman Symposium–Insights Into the New ATA Guidelines: Pediatric Thyroid Cancer. Invited. ATA Annual Meeting 2023. Washington, DC, US.
2023. Polyglandular Syndromes, Hereditary Endocrine Tumor Syndromes, and some other hormones. Invited. 2023 Board Review Course. San Diego, CA, US.
2021. Perspectives from a Pediatric and Adult Endocrinologist: Advances and Gaps in Care Across the Age Spectrum. Invited. 90th Annual Meeting of the American Thyroid Association. Virtual Conference, US.
2021. Polyglandular Autoimmune Disease and Thyroid Gland Neoplasms. Invited. Pediatric Endocrine Society Board Review Course. Virtual Conference, US.
2021. Heredity Endocrine Tumor Syndromes and some "Other Hormones". Invited. Pediatric Endocrine Society Board Review Course. Virtual Conference, US.
2021. Nuclear Medicine for Endocrinologists: Novel Approaches to Imaging Endocrine Disorders (Meet The Professor session). Invited. Pediatric Endocrine Society. Virtual Conference, US.
2021. Thyroid Disease After Pediatric Cancer Therapy (CME Symposium; Precision Management of Late Endocrine Effects in Cancer Survivors). Invited. Endocrine Society. Virtual Conference, US.
2020. When Should Systemic Therapy be Considered for Pediatric Patients with Thyroid Cancer?. Invited. The 23rd International Thyroid Cancer Survivors' Conference. Virtual Conference, US.
2020. Controversies in Thyroidology: Advanced Pediatric Thyroid Cancer – Treatment Controversies. Invited. American Thyroid Association. Virtual Conference, US.
2019. "How Does Thyroid Cancer Differ When it's in Young People Compared to Adults" and "Taking charge of thyroid cancer management as we move from pediatrics to young adults to adults" and The ABCs of Thyroid Cancer: Understanding Key Terms, Concepts, and Initial Diagnostic and Treatment Steps". Invited. The 22nd International Thyroid Cancer Survivors' Conference. Denver, CO, US.
2019. Familial Pheochromocytoma and Paraganglioma: From Genetics to Clinical Management. Invited. Pediatric Endocrine Society/ Pediatric Academic Society. Baltimore, MD, US.
2019. Heredity Endocrine Tumor Syndromes and some "Other Hormones". Invited. Pediatric Endocrine Society Board Review Course. Baltimore, MD, US.
2019. Polyglandular Autoimmune Disease and Thyroid Gland Neoplasms. Invited. Pediatric Endocrine Society Board Review Course. Baltimore, MD, US.
2019. Pediatric Endocrine Tumors: Hereditary Syndromes and Prospective Monitoring. Invited. Endocrine Society. New Orleans, LA, US.
2018. "How Does Thyroid Cancer Differ When It’s In Young People, Compared To Adults?" and "The ABC's Of Thyroid Cancer: Understanding Key Terms, Concepts, And Initial Diagnostic And Treatment Steps". Conference. 21st International Thyroid Cancer Survivors' Conference. Chicago, IL, US.
2018. Staging Systems in Pediatric and Adult Thyroid Cancer. Invited. The Endocrine Society. Chicago, IL, US.
2018. Meet the Professor: Differentiated Thyroid Cancer in Children. Invited. The Endocrine Society. Chicago, IL, US.
2017. Hereditary Endocrine Tumor Syndromes and some "other hormones". Invited. Pediatric Endocrine Society Board Review Course. Arlington, VA, US.
2017. Polyglandular Autoimmune Disease and Thyroid Gland Neoplasms. Invited. Pediatric Endocrine Society Board Review Course. Arlington, VA, US.
2016. "Helping Children and Teens Cope With Thyroid Cancer. The 2015 Treatment Guidelines of the American Thyroid Association, Differences in Care for Youths and Adults, and the Transition to Adult Care."; "The ABCs of Thyroid Cancer: The Meaning of Key Terms and Concepts."; "Pediatric Thyroid Cancer, and As We Move Into Adulthood.". Conference. 19th International Thyroid Cancer Survivors' Conference. Los Angeles, CA, US.
2016. Pediatric Differentiated Thyroid Cancer Meet-the-Professor. Invited. Endocrine Society's 2016 Clinical Endocrinology Update Meeting. Seattle, WA, US.
2016. Medullary Thyroid Cancer. Invited. Endocrine Society's 2016 Clinical Endocrinology Update Meeting. Seattle, WA, US.
2016. The American Thyroid Association Management Guidelines for Pediatric Thyroid Cancer. Invited. 29th Annual Meeting of the American Society of Pediatric Hematology / Oncology. Minneapolis, MN, US.
2016. Pediatric Endocrine Cancers. Invited. Pediatric Endocrine Society Interactive Clinical Update and Case Discussion Course. Baltimore, MD, US.
2015. "Children and Teens Dealing With Thyroid Cancer. The 2015 American Thyroid Association Treatment Guidelines, Differences in Care for Youths and Adults, and the Transition to Adult Care"; "Pediatric Thyroid Cancer and As We Age"; "The ABCs of Thyroid Cancer: The Meaning of Key Terms". Conference. 18th International Thyroid Cancer Survivors' Conference. St. Louis, MO, US.
2015. Case Discussions with the Experts: Management of Differentiated Thyroid Cancer in the Pediatric Patient, Highlighting the New Pediatric Thyroid Cancer Guidelines. Invited. Pediatric Endocrine Society Annual Meeting. San Diego, CA, US.
2015. Hereditary Endocrine Tumor Syndromes. Invited. Pediatric Endocrine Society Board Review Course. San Diego, CA, US.
2015. Thyroid Gland Neoplasms. Invited. Pediatric Endocrine Society Board Review Course. San Diego, CA, US.
2015. Management of Children with Distant Metastases (2015 ATA Clinical Management Guidelines Symposium on Pediatric Thyroid Cancer). Invited. American Thyroid Association. San Diego, CA, US.
2015. Management of Children with Hereditary MTC (2015 ATA Clinical Management Guidelines Symposium on Medullary Thyroid Cancer). Invited. American Thyroid Association. San Diego, CA, US.
2014. Outlaws in the Saddle: What the Sheriff Needs to Know - Tumors and Cancer Related Disease of the Pituitary. Conference. RSNA 100th Scientific Assembly and Annual Meeting. Chicago, IL, US.
2014. Prophylactic Thyroidectomy in MEN2: When and Why?. Invited. 84th Annual Meeting of the American Thyroid Association. Coronado, CA, US.
2013. The Patient with a Neuroendocrine Tumor: When is Genetic Testing Recommended?. Invited. The Endocrine Society. San Francisco, CA, US.
2013. I-131 Radiotherapy of Pediatric Thyroid Cancer. Invited. The Society for Pediatric Radiology 56th Annual Meeting. San Antonio, TX, US.
2013. Meet the Expert: Thyroid Cancer - Convincing Children, Young Adults and Their Families They Are Going to Survive. Invited. AACE 22nd Annual Scientific & Clinical Congress. Phoenix, AZ, US.
2013. Hereditary Endocrine Tumor Syndromes. Invited. Pediatric Endocrine Society Board Review Course. Arlington, VA, US.
2012. Lumps and Bumps in the Pediatric Thyroid: A Case Based Review for the General Pediatrician. Invited. American Academy of Pediatrics. New Orleans, LA, US.
2012. Endocrine Neoplasia: A Case-Based Discussion. Invited. Pediatric Endocrine Society Spring Retreat Course. Hyannis, MA, US.
2012. Clinical Update: MEN and Endocrine Tumor Syndromes. Invited. Pediatric Endocrine Society Clinical Update Course. Boston, MA, US.
2011. "Ask a Doctor: Understanding your Thyroid Cancer Better at the Start of the Conference"; "Ask a Doctor: Questions About a Medullary Thyroid Cancer Diagnosis"; "Thyroid Cancer, How is the Disease Different for Young People?"; "Thyroid Cancer, How is the Care Different for Young People with Differentiated or Medullary Thyroid Cancer?". Conference. 14th International Thyroid Cancer Survivors' Conference. Los Angeles, CA, US.
2011. Case Management Forum: Thyroid Nodules and Cancers in Children. Invited. The Endocrine Society. Boston, MA, US.
2011. Current Management of MTC and MEN2. Invited. Pediatric Endocrine Society Annual Meeting. Denver, CO, US.
2011. Hereditary Endocrine Tumor Syndromes: An Overview. Invited. Pediatric Endocrine Society Board Review Course. Denver, CO, US.
2011. Audience Participation Panel: What Do I Do Now? Management of Routine and Complex Thyroid Issues: The Surgical Perspective. Invited. The American Association of Endocrine Surgeons 32nd Annual Meeting. Houston, TX, US.
2011. Pheochromocytoma (Core Lectures-The Pediatric Patient with Endocrine Disorders). Invited. Society for Pediatric Anesthesia. San Diego, CA, US.
2010. New ATA Guidelines and How They Impact Young Adult Thyroid Cancer Patients. Invited. Sixth Annual Oncology Congress. San Francisco, CA, US.
2009. Meet the Expert: Pheochromocytoma and Paraganglioma. Invited. 8th Joint Meeting of the Lawson Wilkins Pediatric Endocrine Society / European Society for Pediatric Endocrinology. New York, NY, US.
2008. "Roundtable: Patient/Physician Relationships: Effective Communication and Coordination"; "Pediatric Thyroid Cancer: Answering Your Questions"; "Roundtable: Pediatric and Young Adults". Conference. 11th International Thyroid Cancer Survivors' Conference. St. Louis, MO, US.
2007. Pediatric Thyroid Cancer, Meet the Professor. Invited. 78th Annual American Thyroid Association Meeting. New York, NY, US.
2006. "Ask a Doctor about the First Five Years Dealing with Papillary and Follicular Thyroid Cancer"; "Papillary and/or Follicular Recurrence Risk Factors and How They Affect Initial Treatment and Follow-up"; "Roundtable: Young Adults Group; Pediatric Thyroid Cancer: Answering Your Questions about Treatment, Testing and Research". Conference. 9th International Thyroid Cancer Survivors' Conference. Orlando, FL, US.
2006. Pediatric Graves Disease. Invited. 77th Annual American Thyroid Association Meeting. Phoenix, AZ, US.
2006. Adrenal Tumors in Children. Invited. M.D. Anderson Endocrine Surgery Update: Abdominal Endocrine Neoplasms. Boston, MA, US.
2005. "Communicating with the Medical Team and Coping with Fears about testing, treatment, recurrence" and "Childhood and Adolescent Thyroid Cancer: Treatment Issues". Conference. 8th International Thyroid Cancer Survivors' Conference. Denver, CO, US.
2003. When a Child or Adolescent Has Thyroid Cancer. Conference. 6th International Thyroid Cancer Survivors' Conference. Houston, TX, US.

International Presentations

2025. Efficacy and Safety of Larotrectinib in Patients with TRK Fusion Differentiated Thyroid Carcinoma (DTC): An Updated Analysis (Awarded 1st place in free paper presentations). Conference. World Congress on Thyroid Cancer 2025. Boston, US.
2025. Pediatric Thyroid Cancer 2025. Panelist. World Congress on Thyroid Cancer 2025. Boston, US.
2025. Pediatric thyroid cancer: Recent advances. Invited. 17th International Thyroid Congress. Rio de Janeiro, BR.
2025. MEN2: Unmet Needs. Invited. 19th World MEN Meeting. São Paulo, BR.
2025. Thyroid Cancer Across the Lifespan: Similar yet Different (Plenary Lecture). Invited. Connecting Endocrinology Across the Life Course: Joint Congress of ESPE and ESE 2025. Copenhagen, DK.
2025. Special Considerations of Systemic Therapy Use in the Pediatric Population. Invited. International Thyroid Oncology Group Annual Meeting. Ann Arbor, US.
2025. Sporadic vs Hereditary Pediatric MTC: Clinical Presentations and Long-term Outcomes. Invited. International Thyroid Oncology Group Annual Meeting. Ann Arbor, US.
2025. TRK Fusion Thyroid Cancer: From Diagnosis to Management. Invited. 18th Endo Congress. Medellin, CO.
2024. Symposium on Pheochromocytoma and Paraganglioma. Panelist. APPES Special Interest Group/APPES-ISPAE Joint Meeting 2024. Virtual.
2024. Update on the Treatment of Malignant Pheochromocytomas and Paragangliomas. Invited. II Curso Internacional Endocrinologia y Oncologia Suprarenal: del Nino al Adulto. Santiago, CL.
2024. Tips on Adrenal Radiology from Children to Adults. Invited. II Curso Internacional Endocrinologia y Oncologia Suprarenal: del Nino al Adulto. Santiago, CL.
2023. The Landscape of Pediatric Thyroid Cancer 2023 (Keynote). Invited. World Congress on Thyroid Cancer 2023. London, GB.
2023. [Instructional Course] Management of Paediatric Thyroid Cancer and Involvement of the Adult Team. Invited. World Congress on Thyroid Cancer 2023. London, GB.
2023. Unmet needs in Genetics and Pediatrics. Invited. WorldMEN 18th International Workshop on Multiple Endocrine Neoplasia and Other Rare Endocrine Tumors. Marseille, FR.
2023. Early thyroidectomy in MEN2. Invited. WorldMEN 18th International Workshop on Multiple Endocrine Neoplasia and Other Rare Endocrine Tumors. Marseille, FR.
2022. Pediatric Thyroid Cancer Tumor Board. Panelist. American Thyroid Association. Montreal, CA.
2022. Thyroid Cancer Systemic Therapy: Results, Challenges and Opportunities. Invited. ENDO Update 2022: Endocrine Oncology. Mumbai, IN.
2022. Management of MTC and MEN2 syndromes in childhood. Invited. ENDO Update 2022: Endocrine Oncology. Mumbai, IN.
2022. MEN1 and MEN2 in Children: An Update on Management. Invited. XXIII Congress of the Mexican Society of Pediatric Endocrinology. Mérida, MX.
2022. Pediatric PTC with Metastases: Clinical Presentation, Prognosis, and Contemporary Approaches to Care. Invited. XXIII Congress of the Mexican Society of Pediatric Endocrinology. Mérida, MX.
2022. An Update on the Management of Papillary Thyroid Carcinoma in Children. Invited. 1st Annual Arab Thyroid Association Congress. Virtual Conference, AE.
2022. Papillary Thyroid Cancer in Children and Adults—Is It the Same Disease?. Invited. Wokół Raka Tarczycy (Around Thyroid Cancer). Gliwice, PL.
2022. Papillary Thyroid Cancer in Children and Adults—Is It the Same Disease?. Invited. European Reference Networks Workshop: "Endocrine Cancer: A Challenge for Children and Adults". Gliwice, PL.
2021. Management of Pediatric Papillary Thyroid Cancer: Past, Present, and Future. Invited. SLEP Workshop 2021. Virtual Conference, AR.
2021. Thyroid Cancer Systemic Therapy: Results and Challenges. Invited. 2nd DTCG Symposium, Groningen. Virtual Conference, NL.
2021. MEN1 in Children. Invited. WorldMEN 17th International Workshop on Multiple Endocrine Neoplasia and Other Rare Endocrine Tumors. Virtual Conference, FR.
2021. MEN1 in Children: Screening Considerations. Invited. WorldMEN 17th International Workshop on Multiple Endocrine Neoplasia and Other Rare Endocrine Tumors. Virtual Conference, FR.
2021. Radioactive Iodine in the Management of DTC in Children. Invited. Emirates Thyroid Virtual Congress 2021. Virtual Conference, AE.
2020. Thyroid Sequelae of Pediatric Cancer Therapy. Invited. XXIX Congress of the Latin American Society of Pediatric Endocrinology | XXI Congress of the Mexican Society of Pediatric Endocrinology. Virtual Conference, MX.
2018. Thyroid Cancer In Childhood – A Focus On Controversial Management Issues And The Recent ATA Guidelines. Invited. APEG Annual Scientific Meeting 2018. Newcastle, AU.
2017. Multiple Endocrine Neoplasia Type 2: Approach to Care and Controversies in Management. Invited. XXVIII Chilean Congress of Endocrinology and Diabetes. Puerto Varas, CL.
2017. Differentiated Thyroid Cancer in Children and Young Adults: Current Management and Why Children Are Not Treated Like Little Adults. Invited. XXVIII Chilean Congress of Endocrinology and Diabetes. Puerto Varas, CL.
2017. Medullary Thyroid Carcinoma: An Update for 2017. Invited. XXVIII Chilean Congress of Endocrinology and Diabetes. Puerto Varas, CL.
2017. Pediatric Thyroid Nodules and Thyroid Cancer: The Endocrine Perspective. Invited. 87th Annual Meeting of the American Thyroid Association. Victoria, CA.
2017. Pediatric Thyroid Neoplasms: An Update. Invited. 49th Congress of The International Society of Paediatric Surgical Oncology. Washington, US.
2017. Management of Pediatric Thyroid Cancer (Panel). Invited. Third World Congress on Thyroid Cancer. Boston, US.
2017. Medullary Thyroid Cancer (Panel). Invited. Third World Congress on Thyroid Cancer. Boston, US.
2016. DTC in childhood: Unique Aspects and Challenges in Management. Invited. 39th Annual Meeting of the European Thyroid Association. Copenhagen, DK.
2015. Pediatric Thyroid Cancer Guidelines (Early Riser Symposium: Differences Between Pediatric and Adult Differentiated Thyroid Cancer). Invited. 15th International Thyroid Congress. Orlando, US.
2015. Differentiated Thyroid Cancer in Childhood: Long-term Outcomes and New Treatment Options. Invited. Canadian Pediatric Endocrine Group 2015 Scientific Meeting. Halifax, CA.
2014. Primary Thyroid Disease after Childhood Cancer Treatment (PES Topic Symposium). Invited. Pediatric Endocrine Society. Vancouver, CA.
2014. Update on New Biology of Thyroid Tumors. Invited. 2014 Clinical Update Course. Vancouver, CA.
2013. Familial Forms of Thyroid Cancer. Invited. 9th Joint Meeting of the European Society for Pediatric Endocrinology and The Pediatric Endocrine Society. Milan, IT.
2013. Meet the Professor: Management of RAI Avid Distant Metastasis in Pediatric Thyroid Cancer. Invited. World Congress on Thyroid Cancer. Toronto, CA.
2012. What Should We Tell Families Affected with Heritable Cancer Syndromes? 2-hour Round Table. Invited. Sandoz Biopharmaceuticals. Munich, DE.
2010. "Thyroid Cancer, How is the Disease Different for Young People?" and "Thyroid Cancer, How is the Care Different for Young People?". Conference. 13th International Thyroid Cancer Survivors' Conference. Dallas, US.
2010. Management of paediatric medullary thyroid carcinoma. Invited. 14th International Thyroid Congress. Paris, FR.
2010. Endocrine Consequences of Childhood Malignancies: The Patient’s Journey Continues. Invited. Pediatric and Adolescent Endocrine and Diabetes Society of South Africa. Durban, ZA.
2010. Meet the Professor: Endocrine consequences of childhood malignancies. Invited. 45th Congress of the Society for Endocrinology, Metabolism and Diabetes of South Africa. Durban, ZA.
2010. Thyroid Malignancies in Children and Young Adults: Current Approaches to Diagnosis and Treatment. Invited. 45th Congress of the Society for Endocrinology, Metabolism and Diabetes of South Africa. Durban, ZA.
2009. Pediatric Thyroid Cancer Meet the Professor. Invited. World Congress on Thyroid Cancer. Toronto, CA.
2006. Pituitary Tumors in Childhood. Invited. 5th RMH Paediatric Symposium. Riyadh, SA.
2006. Pediatric Thyroid Cancer. Invited. 5th RMH Paediatric Symposium. Riyadh, SA.
2006. Update in Pediatric Cushing Syndrome. Invited. 5th RMH Paediatric Symposium. Riyadh, SA.

Formal Peers

2024. Treating Advanced Papillary Thyroid Carcinoma Across the Age Spectrum. Invited. San Francisco, CA, US.
2024. Updates in MTC and MEN2. Invited. San Francisco, CA, US.
2023. "An Update on MEN2", part of a larger case discussion called "Never Ending Circles". Invited. Virtual Conference, PH.
2023. Hereditary Endocrine Tumor Syndromes: Easy as ABC and 123! (2023 Ora Hirsch Pescovitz, M.D. Lectureship in Pediatric Endocrinology). Visiting. Indianapolis, IN, US.
2023. Advanced Differentiated Thyroid Cancer Management: Where Have We Been and Where Are We Going? ( 2023 Ora Hirsch Pescovitz, M.D. Lectureship in Pediatric Endocrinology). Invited. Indianapolis, IN, US.
2023. MEN1 and MEN2 in Children: An Update on Management. Invited. Virtual, PA, US.
2022. Fusion Oncogenes Are Associated With Increased Metastatic Capacity and Persistent Disease in Pediatric Thyroid Cancers: A Discussion (https://www.youtube.com/watch?v=ei6f2u6nqwo&list=PLKIn9wjqDMOm0DCLhGQN77tnT4MPo_Rcg&index=1). Invited. Virtual, US.
2022. Hereditary Endocrine Tumor Syndromes: Easy as ABC and 123!. Invited. Virtual, FL, US.
2021. Medullary Thyroid Carcinoma Across the Age Spectrum. Invited. Virtual, IN, US.
2020. Pediatric Papillary Thyroid Cancer: Current and Future Approaches to Care. Invited. Little Rock, AR, US.
2020. Endocrine Tumors in Children: Looking for Zebras. Invited. New York, NY, US.
2019. Finding the Zebras: An Overview of Pediatric Endocrine Tumors. Visiting. Rochester, MN, US.
2019. Pediatric Differentiated Thyroid Cancer: Management with RAI and Beyond. Visiting. Rochester, MN, US.
2018. University of Pennsylvania Endocrinology Grand Rounds: Current and Future Approaches to the Management of MTC and MEN2. Invited. Philadelphia, PA, US.
2018. Thyroid Cancer in Children. Visiting. Cincinnati, OH, US.
2018. Differentiated Thyroid Cancer: An Update on Staging and the Management of Advanced Disease. Invited. Cincinnati, OH, US.
2018. Differentiated Thyroid Cancer in the Child and Young Adult. Visiting. Perth, AU.
2018. Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2: Past, Present, and Future. Visiting. Perth, AU.
2018. Differentiated Thyroid Cancer: An Update on Staging and the Management of Advanced Disease. Visiting. Perth, AU.
2018. Differentiated Thyroid Cancer: An Update on Staging and the Management of Advanced Disease. Visiting. Perth, AU.
2018. Differentiated Thyroid Cancer: An Update on Staging and the Management of Advanced Disease. Visiting. Perth, AU.
2018. Advanced Pediatric Endocrine Cancers: Current Management and Hope for the Future. Visiting. Perth, AU.
2018. Advanced Pediatric Endocrine Cancers: Current Management and Hope for the Future. Invited. Philadelphia, PA, US.
2017. Lumps and Bumps in the Pediatric Thyroid: Diagnosis and Treatment. Invited. Palo Alto, CA, US.
2017. Medullary Thyroid Cancer and MEN2: An Update for 2017. Invited. Palo Alto, CA, US.
2017. Pediatric Endocrine Tumors: Genetics and Clinical Presentation. Invited. Houston, TX, US.
2016. Pediatric Endocrine Tumors: Clinical Presentation and the Importance of Early Diagnosis. Invited. Columbus, OH, US.
2016. Hereditary Endocrine Cancer Syndromes. Visiting. Toronto, CA.
2016. Pediatric Thyroid Cancer: New Guidelines for Care and Treatment of Advanced Diseases. Visiting. Toronto, CA.
2016. Pediatric Thyroid Cancer: New Guidelines for Care and Treatment of Advanced Disease. Invited. Bethesda, MD, US.
2015. The Child with an Endocrine Tumor: An Overview for the Pediatrician. Invited. Bronx, NY, US.
2015. Pediatric Thyroid Cancer: Current Approaches to Evaluation and Management. Invited. Bronx, NY, US.
2014. Pediatric Thyroid Cancer: Current Approaches to Evaluation and Management. Visiting. Salt Lake City, UT, US.
2014. Pituitary Tumors-A Primer for the General Internist. Invited. Houston, TX, US.
2014. Thyroid Cancer in Children. Invited. Orange, CA, US.
2013. Pediatric Thyroid Cancer: Evolving Approaches to Treatment. Invited. Memphis, TN, US.
2013. The Child with an Endocrine Tumor: Clinical Presentation and the Importance of Early Diagnosis. Visiting. Boston, MA, US.
2013. Pediatric Thyroid Nodules & Papillary Thyroid Cancer: Current Approaches to Diagnosis and Treatment. Invited. Boston, MA, US.
2013. Endocrine Consequences of Cancer Therapies: The Patient’s Journey Continues. Invited. Houston, TX, US.
2012. MTC and MEN2: An Update for 2012. Invited. Nashville, TN, US.
2012. The Child with an Endocrine Tumor: Clinical Presentation and the Importance of Early Diagnosis. Visiting. Torrance, CA, US.
2012. MTC and MEN2: Current and Future Approaches to Care. Visiting. Torrance, CA, US.
2011. The Child with an Endocrine Tumor: Clinical Presentation and the Importance of Early Diagnosis. Invited. Houston, TX, US.
2011. Genetic and Neoplastic Syndromes of the Adrenal Gland: When the Zebra Makes the Hoofbeats. Invited. Indianapolis, IN, US.
2011. Adrenal Tumors in Childhood: A Primer for the Pediatric Endocrinologist. Visiting. Pittsburgh, PA, US.
2011. Lumps and Bumps in the Pediatric Thyroid: Current Approaches to Treatment. Visiting. Pittsburgh, PA, US.
2008. Pediatric Thyroid Cancer: Past, Present, and Future. Invited. Philadelphia, PA, US.
2008. Adrenal Tumors in Childhood: Diagnosis and Treatment. Visiting. Cleveland, OH, US.
2007. Pediatric Thyroid Cancer for the Pediatric Oncologist: Past, Present, and Future; Childhood Papillary Thyroid Cancer: Current Management Strategies. Visiting. Atlanta, GA, US.
2007. Update in Pediatric Pituitary Tumors. Invited. Houston, TX, US.
2007. Update in Pediatric Pituitary Tumors. Invited. Indianapolis, IN, US.
2007. Acromegaly, What's New in 2007?. Invited. Houston, TX, US.
2005. Pediatric Thyroid Cancer: Management Dilemmas a Propos of Case Presentations (with Nicholas Sarlis, MD). Invited. Houston, TX, US.
2004. Growth Hormone Excess Across the Ages. Invited. Houston, TX, US.

Less

Grant & Contract Support

Date:	2014 - 2019
Title:	Fusion Oncogenes as Drivers of Medullary Thyroid Cancer
Funding Source:	American Thyroid Association
Role:	Collaborator

Selected Publications

Peer-Reviewed Articles

Castellanos LE, Bryan J, Ricarte-Filho JC, Franco AT, Alshalalfa M, Klopper JP, Kloos RT, Waguespack SG. Afirma Genomic Sequencing Classifier Performance in Young Patients with Cytologically Indeterminate Thyroid Nodules. J Clin Endocrinol Metab, 2026. e-Pub 2026. PMID: 41678360.
Hamidi S, Vodopivec DM, Busaidy NL, Gule-Monroe M, Akhave NS, Banuchi VE, Ferraroto R, Fournier I, Gunn GB, Iyer PC, Lee A, Maniakas A, Marczyk VR, Ning MS, Sousa LG, Spiotto MT, Waguespack SG, Wang JR, Zafereo ME, Cabanillas ME, Dadu R. Real-World Experience with Lenvatinib plus Pembrolizumab in Metastatic BRAF Wild-Type Anaplastic Thyroid Carcinoma. Thyroid 36(2):153-161, 2026. e-Pub 2026. PMID: 41791883.
Onuma AE, Skefos CM, Richardson ME, Pasyar S, Fergus KB, Bassett RL, Hu MI, Perrier ND, Maniakas A, Zafereo M, Waguespack SG, Sosa JA, Grubbs EG. The shifting landscape of germline RET pathogenic variants with the introduction of panel testing. Surgery 189:109701, 2026. e-Pub 2026. PMID: 41371824.
Kraft IL, Akshintala S, Gross A, Dombi E, Turkbey B, Bednarova S, Ward JF, Yedururi S, Merino M, Pinto PA, Widemann BC, Shern JF, Waguespack SG, Glod J. The Prostate is a Common Site of Disease in Patients with MEN2B and Medullary Thyroid Carcinoma. Endocr Relat Cancer 33(1), 2025. e-Pub 2025. PMID: 41378514.
van de Berg DJ, van Santen HM, Clement SC, Vriens MR, van Trotsenburg ASP, Bruinstroop E, Kruijff S, Peeters RP, Verburg FA, Netea-Maier R, Nieveen van Dijkum EJM, Fugazzola L, Dedecjus M, Visser WE, Baidoo KK, Derikx JPM, Engelsman AF, Differentiated Thyroid Cancer Recurrence Collaboration Group (SGW was a member). International Consensus on the Requirements for Definitions of Complete Remission and Recurrence of Differentiated Thyroid Cancer: a Delphi Study (ICON-DTC). Eur J Endocrinol 193(6):772-782, 2025. e-Pub 2025. PMID: 41289036.
Maniakas A, Wilde DC, Fournier I, Hyde EK, Xu L, Wang JR, Gross ND, Sturgis EM, Banuchi V, Busaidy NL, Cabanillas ME, Iyer P, Dadu R, Waguespack SG, Hu MI, Gunn GB, Kwon M, Ahmed S, Williams MD, Zafereo ME. Segmental Tracheal Resection for Thyroid Cancer: Perioperative Morbidity, Locoregional Control, and Survival. Head Neck 48(3):644-649, 2025. e-Pub 2025. PMID: 41059669.
Fournier I, Bandi AV, Hamidi S, Iyer P, Busaidy NL, Cabanillas ME, Dadu R, Hu MI, Waguespack SG, Basmaci UN, Williams MD, Mansour M, Monroe MG, Gross ND, Goepfert RP, Perrier ND, Banuchi V, Wang JR, Maniakas A, Zafereo ME. Management of Retropharyngeal Lymph Node Metastases in Thyroid Cancer. Head Neck 48(1):237-245, 2025. e-Pub 2025. PMID: 40891104.
Hawes EE, Banuchi VE, Maniakas A, Wang JR, Graham PH, Diersing JD, Busaidy NL, Cabanillas ME, Dadu R, Hamidi S, Iyer P, Waguespack SG, Ahmed S, Alizada S, Belcastro A, Alsharif R, Hu MI, Zafereo ME. Partial Laryngectomy for Thyroid Cancer: A Single Institution Case Series With Operative Techniques. Head Neck 48(2):E20-E24, 2025. e-Pub 2025. PMID: 40747656.
Castellanos LE, Yedururi S, Waguespack SG. Redifferentiation Effect of Larotrectinib for NTRK Fusion-Positive Pediatric Thyroid Cancer and Outcomes After Therapy. J Endocr Soc 9(8):bvaf098, 2025. e-Pub 2025. PMID: 40599338.
Dagher SA, Alizada S, Al Qudah H, Waguespack SG, Shah KB, Eldaya RW. Imaging and clinical course of metastatic pituitary neuroendocrine tumors (PitNET): A single center case series. Neuroradiol J:19714009251356278, 2025. e-Pub 2025. PMID: 40576016.
Hamidi S, Maniakas A, Akhave NS, Banuchi VE, Busaidy NL, Dadu R, Ferrarotto R, Guise TA, Hofmann MC, Hosseini SM, Hu MI, Iyer PC, Mansour M, Marczyk VR, Roy-Chowdhuri S, Sherman SI, Sousa LG, Wang JR, Williams MD, Zafereo ME, Waguespack SG, Cabanillas ME. Characterization of advanced RAS-driven follicular-derived thyroid cancers and review of future therapeutic avenues. J Clin Endocrinol Metab 111(2):471-483, 2025. e-Pub 2025. PMID: 40568752.
Brandi ML, Pieterman CRC, English KA, Lines KE, Shariq OA, Marini F, Cuny T, Lewis MA, Stratakis CA, Perrier ND, Waguespack SG, Castinetti F, Valk GD, Thakker RV. Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice. Lancet Diabetes Endocrinol 13(8):699-721, 2025. e-Pub 2025. PMID: 40523372.
Ballaro R, Wasylishen AR, Pieterman CRC, Olsen C, Irajizad E, Wu R, Katayama H, Liu H, Cai Y, Leon-Letelier RA, Dennison JB, Waguespack S, Do KA, Agarwal SK, Walter M, Welch J, Weinstein L, Blau JE, Jha S, Nilubol N, Vriens MR, van Leeuwaarde RS, van Treijen MJC, Valk GD, Perrier ND, Hanash SM, Fahrmann JF. Elevated levels of circulating microbial-associated uremic toxins are associated with metastatic duodenopancreatic neuroendocrine tumors in patients with Multiple Endocrine Neoplasia Type 1. Cancer Lett 614:217537, 2025. e-Pub 2025. PMID: 39924079.
Marczyk VR, Fazeli S, Dadu R, Busaidy NL, Iyer P, Hu MI, Sherman SI, Hamidi S, Hosseini SM, Williams MD, Ahmed S, Routbort MJ, Luthra R, Roy-Chowdhuri S, San Lucas FA, Patel KP, Hong DS, Zafereo M, Wang JR, Maniakas A, Waguespack SG, Cabanillas ME. NTRK Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy. JCO Precis Oncol 9:e2400321, 2025. e-Pub 2025. PMID: 39983078.
Kothari R, Donner JR, Balakrishnan K, Hartman G, Alazraki A, Antal Z, Bauer A, Chelius D, Cherella C, Dahl JP, Dimachkieh A, Fox LA, Helmig S, Jiang W, Kazahaya K, Laetsch TW, Lodish M, Mahajan P, Parsons L, Prickett K, Quintanilla-Dieck L, Rastatter J, Rothstein DH, Simons J, Sheyn A, Wagner A, Waguespack SG, Wasserman JD, Wassner AJ, Seeley H, Meister KD. Composition and Priorities of Multidisciplinary Pediatric Thyroid Programs: A Consensus Statement. Thyroid 35(4):346-356, 2025. e-Pub 2025. PMID: 39950999.
Castellanos LE, Zafereo ME, Sturgis EM, Wang JR, Ying AK, Waguespack SG. Pediatric Papillary Thyroid Carcinoma: Outcomes After Surgery Without Adjuvant Radioactive Iodine. J Clin Endocrinol Metab 110(2):e208-e217, 2025. e-Pub 2025. PMID: 39163248.
Dudzinski SO, Cabanillas ME, Hamidi S, Marczyk VR, Busaidy NL, Dadu R, Welsh J, Hu MI, Gunn GB, Wang C, Waguespack SG, Phan J, Beckham TH, Chang JY, Sherman SI, Reddy JP, Ying AK, O'Reilly MS, Chen A, Lee A, Gandhi SJ, Liao Z, Ludmir EB, Nguyen QN, Lin SH, Zafereo ME, Ning MS. Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer: A Potential Strategy for Systemic Therapy Deferral. J Natl Compr Canc Netw 23(1):1-7, 2024. e-Pub 2024. PMID: 39662038.
Hamidi S, Yedururi S, Hu MI, Busaidy NL, Sherman SI, Jimenez C, Grubbs EG, Maniakas A, Zafereo ME, Subbiah V, Waguespack SG. Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma. Thyroid 35(1):6-17, 2024. e-Pub 2024. PMID: 39630530.
Szabo Yamashita T, Tame-Elorduy A, Skefos CM, Varghese JM, Habra MA, Fisher SB, Graham PH, Grubbs EG, Waguespack SG, Jimenez C, Perrier ND. SDHB-Associated Pheochromocytomas: What is Their Clinical Behavior?. Ann Surg Oncol 31(13):9007-9013, 2024. e-Pub 2024. PMID: 39382746.
Casey RT, Hendriks E, Deal C, Waguespack SG, Wiegering V, Redlich A, Akker S, Prasad R, Fassnacht M, Clifton-Bligh R, Amar L, Bornstein S, Canu L, Charmandari E, Chrisoulidou A, Freixes MC, de Krijger R, de Sanctis L, Fojo A, Ghia AJ, Huebner A, Kosmoliaptsis V, Kuhlen M, Raffaelli M, Lussey-Lepoutre C, Marks SD, Nilubol N, Parasiliti-Caprino M, Timmers HHJLM, Zietlow AL, Robledo M, Gimenez-Roqueplo AP, Grossman AB, Taieb D, Maher ER, Lenders JWM, Eisenhofer G, Jimenez C, Pacak K, Pamporaki C. International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents. Nat Rev Endocrinol 20(12):729-748, 2024. e-Pub 2024. PMID: 39147856.
Hicks K, Graf J, Zafar S, Waguespack SG. Case 3: Psychiatric Distress, Hypertension, and Weight Gain in an Adolescent Male. Pediatr Rev 45(9):513-517, 2024. e-Pub 2024. PMID: 39217127.
Elsayes AK, Waguespack SG, Matta EJ, Wang MX. Adrenal Hemangioma. JCEM Case Rep 2(9):luae162, 2024. e-Pub 2024. PMID: 39286519.
Feldman HA, Busaidy NL, Tame-Elorduy A, Silva AK, Halfteck G, Merriman K, Waguespack SG, Graham PH, Williams MD, Perrier ND. Clinical course of atypical parathyroid neoplasm with soft tissue extension. J Surg Oncol 130(5):1092-1096, 2024. e-Pub 2024. PMID: 39155668.
Hensley SG, Hu MI, Bassett RL, Ying AK, Zafereo ME, Perrier ND, Busaidy NL, Hyde SM, Grubbs EG, Waguespack SG. Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-Term Outcomes in 144 Patients Over 6 Decades. J Clin Endocrinol Metab 109(9):2256-2268, 2024. e-Pub 2024. PMID: 38441533.
Al-Ward R, Brondani VB, Sawani S, Potter CL, Xu G, Waguespack SG, Varghese J, Habra MA, Lu Y, Jimenez C. High-Specific-Activity 131I-MIBG for the Treatment of Advanced Pheochromocytoma and Paraganglioma. Clin Nucl Med 49(7):610-620, 2024. e-Pub 2024. PMID: 38630996.
Laganà M, Balderrama-Brondani V, Herrera KR, Chahla B, Yaylaci F, Bassett RL, Jimenez C, Varghese J, Waguespack SG, Campbell MT, Shah AY, Rojas Hernandez CM, Habra MA. Venous thromboembolism in adrenocortical carcinoma: a retrospective analysis. Oncologist 29(7):575-580, 2024. e-Pub 2024. PMID: 38776552.
Shirali AS, Hu MI, Chiang YJ, Graham PH, Fisher SB, Sosa JA, Perrier N, Brown S, Holla VR, Dadu R, Busaidy N, Sherman SI, Cabanillas M, Waguespack SG, Zafereo ME, Grubbs EG. Next-Generation Sequencing in Sporadic Medullary Thyroid Cancer Patients: Mutation Profile and Disease Aggressiveness. J Endocr Soc 8(6):bvae048, 2024. e-Pub 2024. PMID: 38660141.
Waguespack SG, Somaiah N, Lee JE, Elsayes KM. Incomplete Carney Triad. JCEM Case Rep 2(2):luae016, 2024. e-Pub 2024. PMID: 38405102.
Clemente-Gutierrez U, Pieterman CRC, Lui MS, Yamashita TS, Tame-Elorduy A, Huang BL, Shirali AS, Erstad DJ, Lee JE, Fisher SB, Graham PH, Grubbs EG, Waguespack SG, Ng CS, Perrier N. Beyond the 3 P's: Adrenal involvement in MEN1. Endocr Relat Cancer 31(2), 2024. e-Pub 2024. PMID: 38108666.
Maniakas A, Sullivan A, Hu MI, Busaidy NL, Cabanillas ME, Dadu R, Waguespack SG, Fisher SB, Graham PH, Gross ND, Grubbs EG, Perrier ND, Wang JR, Gunn B, Garden AS, Megahed R, Navuluri S, Li X, Williams MD, Zafereo M. Decreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer. Head Neck 46(2):328-335, 2024. e-Pub 2024. PMID: 38009416.
Balderrama-Brondani V, Griffin AM, Owen TJ, Merriman KW, Chahla BB, Varghese J, Jimenez C, Waguespack SG, Graham PH, Perrier ND, Fisher SB, Karam JA, Shah AY, Campbell M, Hassan MM, Habra MA. Incidence and Geographical Distribution of Adrenocortical Carcinoma: Retrospective Analysis of a State Cancer Registry. Endocr Pract 30(1):25-30, 2024. e-Pub 2024. PMID: 37858722.
Contrera KJ, Phan J, Waguespack SG, Aldehaim M, Wang X, Lim TY, Roberts DB, Fuller CD, Spiotto MT, Raza SM, DeMonte F, Hanna EY, Su SY. Prevalence of pituitary hormone dysfunction following radiotherapy for sinonasal and nasopharyngeal malignancies. Head Neck 45(10):2525-2532, 2023. e-Pub 2023. PMID: 37534890.
Daniels AB, Tirosh A, Huntoon K, Mehta GU, Spiess PE, Friedman DL, Waguespack SG, Kilkelly JE, Rednam S, Pruthi S, Jonasch EA, Baum L, Chahoud J, Guidelines Consortium IVS. Guidelines for surveillance of patients with von Hippel-Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance. Cancer 129(19):2927-2940, 2023. e-Pub 2023. PMID: 37337409.
Jimenez C, Ma J, Roman Gonzalez A, Varghese J, Zhang M, Perrier N, Habra MA, Graham P, Waguespack SG. TNM Staging and Overall Survival in Patients with Pheochromocytoma and Sympathetic Paraganglioma. J Clin Endocrinol Metab 108(5):1132-1142, 2023. e-Pub 2023. PMID: 36433823.
Contrera KJ, Gule-Monroe MK, Hu MI, Cabanillas ME, Busaidy NL, Dadu R, Waguespack SG, Wang JR, Maniakas A, Lai SY, Diersing J, Kwon M, Grubbs EG, Subbiah V, Williams MD, Zafereo ME. Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series. Thyroid 33(1):129-132, 2023. e-Pub 2023. PMID: 36503246.
Landry JP, Clemente-Gutierrez U, Pieterman CRC, Chiang YJ, Waguespack SG, Jimenez C, Habra MA, Halperin DM, Fisher SB, Graham PH, Perrier ND. Management of adrenocorticotropic hormone-secreting neuroendocrine tumors and the role of bilateral adrenalectomy in ectopic Cushing syndrome. Surgery 172(2):559-566, 2022. e-Pub 2022. PMID: 35437162.
Landry JP, Pieterman CRC, Clemente-Gutierrez U, Grubbs EG, Fisher SB, Graham PH, Waguespack SG, Perrier ND. Evaluation of risk factors, long-term outcomes, and immediate and delayed autotransplantation to minimize postsurgical hypoparathyroidism in multiple endocrine neoplasia type 1 (MEN1): A retrospective cohort study. Surgery 171(5):1240-1246, 2022. e-Pub 2022. PMID: 34952716.
Waguespack SG, Tewari SO, Busaidy NL, Zafereo ME. Larotrectinib Before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion-Positive Papillary Thyroid Carcinoma: Time to Reconsider the Treatment Paradigm for Distantly Metastatic Disease?. JCO Precis Oncol 6:e2100467, 2022. e-Pub 2022. PMID: 35420905.
Waguespack SG, Drilon A, Lin JJ, Brose MS, McDermott R, Almubarak M, Bauman J, Casanova M, Krishnamurthy A, Kummar S, Leyvraz S, Oh DY, Park K, Sohal D, Sherman E, Norenberg R, Silvertown JD, Brega N, Hong DS, Cabanillas ME. Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma. Eur J Endocrinol 186(6):631-643, 2022. e-Pub 2022. PMID: 35333737.
Daher M, Varghese J, Gruschkus SK, Jimenez C, Waguespack SG, Bedrose S, Altameemi L, Bazerbashi H, Naing A, Subaiah V, Campbell MT, Shah AY, Zhang M, Sheth RA, Karam JA, Wood CG, Perrier ND, Graham PH, Lee JE, Habra MA. Temporal Trends in Outcomes in Patients with Adrenocortical Carcinoma: A Multidisciplinary Referral Center Experience. J Clin Endocrinol Metab 107(5):1239-1246, 2022. e-Pub 2022. PMID: 35092681.
Banik GL, Shindo ML, Kraimer KL, Manzione KL, Reddy A, Kazahaya K, Bauer AJ, Rastatter JC, Zafereo ME, Waguespack SG, Chelius DC, Quintanilla-Dieck L. Prevalence and Risk Factors for Multifocality in Pediatric Thyroid Cancer. JAMA Otolaryngol Head Neck Surg 147(12):1100-1106, 2021. e-Pub 2021. PMID: 34734994.
Shirali AS, Pieterman CRC, Lewis MA, Hyde SM, Makawita S, Dasari A, Thosani N, Ikoma N, McCutcheon IE, Waguespack SG, Perrier ND. It's not a mystery, it's in the history: Multidisciplinary management of multiple endocrine neoplasia type 1. CA Cancer J Clin 71(5):369-380, 2021. e-Pub 2021. PMID: 34061974.
Hu MI, Waguespack SG, Dosiou C, Ladenson PW, Livhits MJ, Wirth LJ, Sadow PM, Krane JF, Stack BC, Zafereo ME, Ali SZ, Weitzman SP, Hao Y, Babiarz JE, Kennedy GC, Kloos RT. Afirma Genomic Sequencing Classifier & Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules. J Clin Endocrinol Metab 106(8):2198-2207, 2021. e-Pub 2021. PMID: 34009369.
Shojaie D, Hoffman AS, Amaku R, Cabanillas ME, Sosa JA, Waguespack SG, Zafereo ME, Hu MI, Grubbs EE. Decision Making When Cancer Becomes Chronic: Needs Assessment for a Web-Based Medullary Thyroid Carcinoma Patient Decision Aid. JMIR Form Res 5(7):e27484, 2021. e-Pub 2021. PMID: 34269691.
Nguyen H, Shah K, Waguespack SG, Hu MI, Habra MA, Cabanillas ME, Busaidy NL, Bassett R, Zhou S, Iyer PC, Simmons G, Kaya D, Pitteloud M, Subudhi SK, Diab A, Dadu R. Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns. Endocr Relat Cancer 28(7):419-431, 2021. e-Pub 2021. PMID: 33890870.
Nies M, Vassilopoulou-Sellin R, Bassett RL, Yedururi S, Zafereo ME, Cabanillas ME, Sherman SI, Links TP, Waguespack SG. Distant metastases from childhood differentiated thyroid carcinoma: clinical course and mutational landscape. J Clin Endocrinol Metab 106(4):e1683-e1697, 2021. e-Pub 2021. PMID: 33382403.
Bancos I, Atkinson E, Eng C, Young WF, Neumann HPH, Pheochromocytoma I, Group PS. Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature. Lancet Diabetes Endocrinol 9(1):13-21, 2021. e-Pub 2021. PMID: 33248478.
Pieterman CRC, Hyde SM, Wu SY, Landry JP, Chiang YJ, Christakis I, Grubbs EG, Fisher SB, Graham PH, Waguespack SG, Perrier ND. Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies. Surgery 169(1):175-184, 2021. e-Pub 2021. PMID: 32703679.
Jozaghi Y, Zafereo M, Williams MD, Gule-Monroe MK, Wang J, Grubbs EG, Vaporciyan A, Hu MI, Busaidy N, Dadu R, Waguespack SG, Subbiah V, Cabanillas M. Neoadjuvant selpercatinib for advanced medullary thyroid cancer. Head Neck 43(1):E7-E12, 2021. e-Pub 2021. PMID: 33169506.
Majd N, Waguespack SG, Janku F, Fu S, Penas-Prado M, Xu M, Alshawa A, Kamiya-Matsuoka C, Raza SM, McCutcheon IE, Naing A. Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study. J Immunother Cancer 8(2), 2020. e-Pub 2020. PMID: 33427689.
Krane JF, Cibas ES, Endo M, Marqusee E, Hu MI, Nasr CE, Waguespack SG, Wirth LJ, Kloos RT. The Afirma Xpression Atlas for thyroid nodules and thyroid cancer metastases: Insights to inform clinical decision-making from a fine-needle aspiration sample. Cancer Cytopathol 128(7):452-459, 2020. e-Pub 2020. PMID: 32543766.
Jozaghi Y, Zafereo ME, Perrier ND, Wang JR, Grubbs E, Gross ND, Fisher S, Sturgis EM, Goepfert RP, Lai SY, Best C, Busaidy NL, Cabanillas ME, Dadu R, Gagel RF, Habra MA, Hu MI, Jimenez C, Sherman SI, Thosani S, Varghese J, Waguespack SG, Weitzman S, Ying AK, Graham PH. Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines. Head Neck 42(6):1325-1328, 2020. e-Pub 2020. PMID: 32437031.
Wu SY, Chiang YJ, Fisher SB, Sturgis EM, Zafereo ME, Nguyen S, Grubbs EG, Graham PH, Lee JE, Waguespack SG, Perrier ND. Risks of Hypoparathyroidism After Total Thyroidectomy in Children: A 21-Year Experience in a High-Volume Cancer Center. World J Surg 44(2):442-451, 2020. e-Pub 2020. PMID: 31686157.
Brown SJ, Waguespack SG, Chuang HH, Murphy WA, Hu MI. “Detecting the Undetectable”. Clinical Thyroidology 32(1):39-42, 2020. e-Pub 2020.
Santos-Pinheiro F, Penas-Prado M, Kamiya-Matsuoka C, Waguespack SG, Mahajan A, Brown P, Shah K, Fuller GN, McCutcheon I. Treatment and long-term outcomes in pituitary carcinoma: a cohort study. Eur J Endocrinol 181(4):397-407, 2019. e-Pub 2019. PMID: 31349217.
Morani AC, Mubarak AI, Bhosale HR, Ramani NS, Waguespack SG, Ying A. Steroid Cell Ovarian Tumor in a Case of von Hippel-Lindau Disease: Demonstrating Lipid Content of the Mass with MR Imaging. Magn Reson Med Sci 18(4):251-252, 2019. e-Pub 2019. PMID: 30700659.
Kutahyalioglu M, Nguyen HT, Kwatampora L, Clarke C, Silva A, Ibrahim E, Waguespack SG, Cabanillas ME, Jimenez C, Hu MI, Sherman SI, Kopetz S, Broaddus R, Dadu R, Wanland K, Williams M, Zafereo M, Perrier N, Busaidy NL. Genetic profiling as a clinical tool in advanced parathyroid carcinoma. J Cancer Res Clin Oncol 145(8):1977-1986, 2019. e-Pub 2019. PMID: 31309300.
Wannachalee T, Turcu AF, Bancos I, Habra MA, Avram AM, Chuang HH, Waguespack SG, Auchus RJ. The Clinical Impact of [68 Ga]-DOTATATE PET/CT for the Diagnosis and Management of Ectopic Adrenocorticotropic Hormone - Secreting Tumors. Clin Endocrinol (Oxf) 91(2):288-294, 2019. e-Pub 2019. PMID: 31066920.
Castinetti F, Waguespack SG, Machens A, Uchino S, Hasse-Lazar K, Sanso G, Else T, Dvorakova S, Qi XP, Elisei R, Maia AL, Glod J, Lourenço DM, Valdes N, Mathiesen J, Wohllk N, Bandgar TR, Drui D, Korbonits M, Druce MR, Brain C, Kurzawinski T, Patocs A, Bugalho MJ, Lacroix A, Caron P, Fainstein-Day P, Borson Chazot F, Klein M, Links TP, Letizia C, Fugazzola L, Chabre O, Canu L, Cohen R, Tabarin A, Spehar Uroic A, Maiter D, Laboureau S, Mian C, Peczkowska M, Sebag F, Brue T, Mirebeau-Prunier D, Leclerc L, Bausch B, Berdelou A, Sukurai A, Vlcek P, Krajewska J, Barontini M, Vaz Ferreira Vargas C, Valerio L, Ceolin L, Akshintala S, Hoff A, Godballe C, Jarzab B, Jimenez C, Eng C, Imai T, Schlumberger M, Grubbs E, Dralle H, Neumann HP, Baudin E. Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study. Lancet Diabetes Endocrinol 7(3):213-220, 2019. e-Pub 2019. PMID: 30660595.
Ting J, Bell D, Ahmed S, Ying A, Waguespack SG, Tu SM, Weber R, Zafereo M. Primary Malignant Thyroid Teratoma: An Institutional Experience. Thyroid 29(2):229-236, 2019. e-Pub 2019. PMID: 30759052.
Fisher SB, Cote GJ, Bui-Griffith JH, Lu W, Tang X, Hai T, Fisher KE, Williams MD, Wistuba II, Waguespack SG, Dorman CM, Ludwig MS, Graham PH, Perrier ND, Lee JE, Grubbs EG. Genetic characterization of medullary thyroid cancer in childhood survivors of the Chernobyl accident. Surgery 165(1):58-63, 2019. e-Pub 2019. PMID: 30392857.
Angell TE, Wirth LJ, Cabanillas ME, Shindo ML, Cibas ES, Babiarz JE, Hao Y, Kim SY, Walsh PS, Huang J, Kloos RT, Kennedy GC, Waguespack SG. Analytical and Clinical Validation of Expressed Variants and Fusions From the Whole Transcriptome of Thyroid FNA Samples. Front Endocrinol (Lausanne) 10:612, 2019. e-Pub 2019. PMID: 31572297.
Amit M, Boonsripitayanon M, Goepfert RP, Tam S, Busaidy NL, Cabanillas ME, Dadu R, Varghese J, Waguespack SG, Gross ND, Graham P, Williams MD, Sturgis EM, Zafereo ME. Extrathyroidal Extension: Does Strap Muscle Invasion Alone Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer?. Ann Surg Oncol 25(11):3380-3388, 2018. e-Pub 2018. PMID: 30022274.
Tam S, Boonsripitayanon M, Amit M, Fellman BM, Li Y, Busaidy NL, Cabanillas ME, Dadu R, Sherman S, Waguespack SG, Williams MD, Goepfert RP, Gross ND, Perrier ND, Sturgis EM, Zafereo ME. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions. Thyroid 28(10):1301-1310, 2018. e-Pub 2018. PMID: 30141373.
Iyer PC, Cabanillas ME, Waguespack SG, Hu MI, Thosani S, Lavis VR, Busaidy NL, Subudhi SK, Diab A, Dadu R. Immune-Related Thyroiditis with Immune Checkpoint Inhibitors. Thyroid 28(10):1243-1251, 2018. e-Pub 2018. PMID: 30132401.
Jonasch E, McCutcheon IE, Gombos DS, Ahrar K, Perrier ND, Liu D, Robichaux CC, Villarreal MF, Weldon JA, Woodson AH, Pilie PG, Fuller GN, Waguespack SG, Matin SF. Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial. Lancet Oncol 19(10):1351-1359, 2018. e-Pub 2018. PMID: 30236511.
Jaber T, Waguespack SG, Cabanillas ME, Elbanan M, Vu T, Dadu R, Sherman SI, Amit M, Santos EB, Zafereo M, Busaidy NL. Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine. J Clin Endocrinol Metab 103(10):3698-3705, 2018. e-Pub 2018. PMID: 30032208.
Tam S, Amit M, Boonsripitayanon M, Busaidy NL, Cabanillas ME, Waguespack SG, Gross ND, Grubbs EG, Williams MD, Lai SY, Sturgis EM, Zafereo ME. Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer. Thyroid 28(8):982-990, 2018. e-Pub 2018. PMID: 29936892.
Roman-Gonzalez A, Zhou S, Ayala-Ramirez M, Shen C, Waguespack SG, Habra MA, Karam JA, Perrier N, Wood CG, Jimenez C. Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma. Ann Surg 268(1):172-178, 2018. e-Pub 2018. PMID: 28257320.
Romero Arenas MA, Rich TA, Hyde SM, Busaidy NL, Cote GJ, Hu MI, Gagel RF, Gidley PW, Jimenez C, Kupferman ME, Peterson SK, Sherman SI, Ying A, Bassett RL, Waguespack SG, Perrier ND, Grubbs EG. Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma. Ann Surg Oncol 25(5):1395-1402, 2018. e-Pub 2018. PMID: 29427212.
Kraft IL, Akshintala S, Zhu YJ, Lei H, Derse-Anthony C, Dombi E, Steinberg SM, Lodish M, Waguespack SG, Kapustina O, Fox E, Balis FM, Merino MJ, Meltzer PS, Glod J, Shern JF, Widemann BC. Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib. Clin Cancer Res 24(4):753-765, 2018. e-Pub 2018. PMID: 29187393.
Pena I, Clayman GL, Grubbs EG, Bergeron JM, Waguespack SG, Cabanillas ME, Dadu R, Hu MI, Fellman BM, Li Y, Gross ND, Lai SY, Sturgis EM, Zafereo ME. Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer. Head Neck 40(1):79-85, 2018. e-Pub 2018. PMID: 29044788.
Dekker BL, Newbold KL, Führer D, Waguespack SG, Handkiewicz-Junak D, Links TP, Thyroid Cancer EIOCOP. Survey on Paediatric Differentiated Thyroid Cancer Care in Europe. Horm Res Paediatr 89(1):58-62, 2018. e-Pub 2018. PMID: 29151082.
Chinn SB, Zafereo ME, Waguespack SG, Edeiken BS, Roberts DB, Clayman GL. Long-Term Outcomes of Lateral Neck Dissection in Patients with Recurrent or Persistent Well-Differentiated Thyroid Cancer. Thyroid 27(10):1291-1299, 2017. e-Pub 2017. PMID: 28806882.
AbdelBaki MS, Waguespack SG, Salceda V, Jones J, Stapleton SL, Baskin DS, Okcu MF. Significant response of pituitary carcinoma to carboplatin, leucovorin and fluorouracil chemotherapy: a pediatric case report and review of the literature. J Neurooncol 135(1):213-215, 2017. e-Pub 2017. PMID: 28667593.
Khan MI, Clayman GL, Waguespack SG. VISUAL VIGNETTE. Endocr Pract 23(9):1160, 2017. e-Pub 2017. PMID: 28448755.
Cote GJ, Evers C, Hu MI, Grubbs EG, Williams MD, Hai T, Duose DY, Houston MR, Bui JH, Mehrotra M, Waguespack SG, Busaidy NL, Cabanillas ME, Habra MA, Luthra R, Sherman SI. Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients With Advanced Medullary Thyroid Carcinoma. J Clin Endocrinol Metab 102(9):3591-3599, 2017. e-Pub 2017. PMID: 28911154.
Voss RK, Feng L, Lee JE, Perrier ND, Graham PH, Hyde SM, Nieves-Munoz F, Cabanillas ME, Waguespack SG, Cote GJ, Gagel RF, Grubbs EG. Medullary Thyroid Carcinoma in MEN2A: ATA Moderate or High-Risk RET Mutations Do Not Predict Disease Aggressiveness. J Clin Endocrinol Metab 102(8):2807-2813, 2017. e-Pub 2017. PMID: 28609830.
Vanden Borre P, Schrock AB, Anderson PM, Morris JC, Heilmann AM, Holmes O, Wang K, Johnson A, Waguespack SG, Ou SI, Khan S, Fung KM, Stephens PJ, Erlich RL, Miller VA, Ross JS, Ali SM. Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions. Oncologist 22(3):255-263, 2017. e-Pub 2017. PMID: 28209747.
Khan MI, Waguespack SG, Aloia TA, Grubbs EG, Habra MA. De Novo Development of a Cortisol-Producing Adrenocortical Carcinoma in a Patient with Primary Adrenal Insufficiency. AACE Clinical Case Reports 3(2), 2017. e-Pub 2017.
Silva AM, Vodopivec D, Christakis I, Lyons G, Wei Q, Waguespack SG, Petak SM, Grubbs E, Lee JE, Perrier N. Operative intervention for primary hyperparathyroidism offers greater bone recovery in patients with sporadic disease than in those with multiple endocrine neoplasia type 1-related hyperparathyroidism. Surgery 161(1):107-115, 2017. e-Pub 2017. PMID: 27842919.
Xu JY, Murphy WA, Milton DR, Jimenez C, Rao SN, Habra MA, Waguespack SG, Dadu R, Gagel RF, Ying AK, Cabanillas ME, Weitzman SP, Busaidy NL, Sellin RV, Grubbs E, Sherman SI, Hu MI. Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma. J Clin Endocrinol Metab 101(12):jc20162815, 2016. e-Pub 2016. PMID: 27662441.
Xu JY, Grubbs EG, Waguespack SG, Jimenez C, Gagel RF, Sosa JA, Sellin RV, Dadu R, Hu MI, Trotter CS, Jackson M, Rich TA, Hyde SM, Sherman SI, Cote GJ. Medullary Thyroid Carcinoma Associated with Germline RET(K666N) Mutation. Thyroid 26(12):1744-1751, 2016. e-Pub 2016. PMID: 27673361.
Xu JY, Handy B, Michaelis CL, Waguespack SG, Hu MI, Busaidy N, Jimenez C, Cabanillas ME, Fritsche HA, Cote GJ, Sherman SI. Detection and Prognostic Significance of Circulating Tumor Cells in Patients with Metastatic Thyroid Cancer. J Clin Endocrinol Metab 101(11):jc20162567, 2016. e-Pub 2016. PMID: 27575943.
Kamiya-Matsuoka C, Cachia D, Waguespack SG, Crane CH, Mahajan A, Brown PD, Nam JY, McCutcheon IE, Penas-Prado M. Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma. Pituitary 19(4):415-21, 2016. e-Pub 2016. PMID: 27106209.
Ozsari L, Kutahyalioglu M, Elsayes KM, Vicens RA, Sircar K, Jazaerly T, Waguespack SG, Busaidy NL, Cabanillas ME, Dadu R, Hu MI, Vassilopoulou-Sellin R, Jimenez C, Lee JE, Habra MA. Preexisting adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosis. Endocrine 51(2):351-9, 2016. e-Pub 2016. PMID: 26206754.
Dadu R, Hu MI, Cleeland C, Busaidy NL, Habra M, Waguespack SG, Sherman SI, Ying A, Fox P, Cabanillas ME. The efficacy of the natural clay, Calcium Aluminosilicate Anti-Diarrheal (CASAD), in reducing medullary thyroid cancer-related diarrhea and its effects on quality of life: a pilot study. Thyroid 25(10):1085-90, 2015. e-Pub 2015. PMID: 26200040.
Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S, Task Force ATAG. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Pediatric Thyroid Cancer. Thyroid 25(7):716-59, 2015. e-Pub 2015. PMID: 25900731.
Raman S, Grimberg A, Waguespack SG, Miller BS, Sklar CA, Meacham LR, Patterson BC. Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy - A Report from the Pediatric Endocrine Society Drug and Therapeutics Committee. J Clin Endocrinol Metab 100(6):jc20151002, 2015. e-Pub 2015. PMID: 25839904.
Wells SA, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG. Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma The American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Thyroid 25(6):567-610, 2015. e-Pub 2015. PMID: 25810047.
Ferguson SD, Waguespack SG, Langford LA, Ater JL, McCutcheon IE. Fatal juvenile xanthogranuloma presenting as a sellar lesion: case report and literature review. Childs Nerv Syst 31(5):777-84, 2015. e-Pub 2015. PMID: 25503249.
Grubbs EG, Ng PK, Bui J, Busaidy NL, Chen K, Lee JE, Lu X, Lu H, Meric-Bernstam F, Mills GB, Palmer G, Perrier ND, Scott KL, Shaw KR, Waguespack SG, Williams MD, Yelensky R, Cote GJ. RET fusion as a novel driver of medullary thyroid carcinoma. J Clin Endocrinol Metab 100(3):jc20144153, 2015. e-Pub 2015. PMID: 25546157.
Dadu R, Shah K, Busaidy NL, Waguespack SG, Habra MA, Ying AK, Hu MI, Bassett R, Jimenez C, Sherman SI, Cabanillas ME. Efficacy and Tolerability of Vemurafenib in Patients with BRAF(V600E) -Positive Papillary Thyroid Cancer: M.D. Anderson Cancer Center Off Label Experience. J Clin Endocrinol Metab 100(1):E77-81, 2015. e-Pub 2015. PMID: 25353071.
Falchook GS, Millward M, Hong D, Naing A, Piha-Paul S, Waguespack SG, Cabanillas ME, Sherman SI, Ma B, Curtis M, Goodman V, Kurzrock R. BRAF Inhibitor Dabrafenib in Patients with Metastatic BRAF-Mutant Thyroid Cancer. Thyroid 25(1):71-7, 2015. e-Pub 2015. PMID: 25285888.
Verma J, McCutcheon IE, Waguespack SG, Mahajan A. Feasibility and outcome of re-irradiation in the treatment of multiply recurrent pituitary adenomas. Pituitary 17(6):539-45, 2014. e-Pub 2014. PMID: 24272035.
Rich TA, Feng L, Busaidy N, Cote GJ, Gagel RF, Hu M, Jimenez C, Lee JE, Perrier N, Sherman SI, Waguespack SG, Ying A, Grubbs E. Prevalence by Age and Predictors of Medullary Thyroid Cancer in Patients with Lower Risk Germline RET Proto-Oncogene Mutations. Thyroid 24(7):1096-106, 2014. e-Pub 2014. PMID: 24617864.
Dadu R, Devine C, Hernandez M, Waguespack SG, Busaidy NL, Hu MI, Jimenez C, Habra MA, Sellin RV, Ying AK, Cote GJ, Sherman SI, Cabanillas ME. Role of salvage targeted therapy in differentiated thyroid cancer patients who failed first-line sorafenib. J Clin Endocrinol Metab 99(6):jc20133588, 2014. e-Pub 2014. PMID: 24628550.
Dadu R, Waguespack SG, Sherman SI, Hu MI, Busaidy NL, Jimenez C, Habra MA, Ying AK, Bassett RL, Cabanillas ME. Efficacy and tolerability of different starting doses of sorafenib in patients with differentiated thyroid cancer. Oncologist 19(5):477-82, 2014. e-Pub 2014. PMID: 24733667.
Romero Arenas MA, Morris LF, Rich TA, Cote GJ, Grubbs EG, Waguespack SG, Perrier ND. Preoperative multiple endocrine neoplasia type 1 diagnosis improves the surgical outcomes of pediatric patients with primary hyperparathyroidism. J Pediatr Surg 49(4):546-50, 2014. e-Pub 2014. PMID: 24726110.
Shawa H, Elsayes KM, Javadi S, Morani A, Williams MD, Lee JE, Waguespack SG, Busaidy NL, Vassilopoulou-Sellin R, Jimenez C, Habra MA. Adrenal ganglioneuroma: features and outcomes of 27 cases at a referral cancer centre. Clin Endocrinol (Oxf) 80(3):342-7, 2014. e-Pub 2014. PMID: 24033606.
Shawa H, Vassilopoulou-Sellin R, Waguespack SG. Visual vignette. Endocr Pract 20(2):191, 2014. e-Pub 2014. PMID: 24678544.
Ayala-Ramirez M, Jasim S, Feng L, Ejaz S, Deniz F, Busaidy N, Waguespack SG, Naing A, Sircar K, Wood CG, Pagliaro L, Jimenez C, Vassilopoulou-Sellin R, Habra MA. Adrenocortical carcinoma: Clinical outcomes and prognosis of 330 patients at a tertiary care center. Eur J Endocrinol 169(6):891-9, 2013. e-Pub 2013. PMID: 24086089.
Morris LF, Harris RS, Milton DR, Waguespack SG, Habra MA, Jimenez C, Vassilopoulou-Sellin R, Lee JE, Perrier ND, Grubbs EG. Impact and timing of bilateral adrenalectomy for refractory adrenocorticotropic hormone-dependent Cushing s syndrome. Surgery 154(6):1174-83; discussion 1183-4, 2013. e-Pub 2013. PMID: 24383115.
Thosani S, Ayala-Ramirez M, Palmer L, Hu MI, Rich T, Gagel RF, Cote G, Waguespack SG, Habra MA, Jimenez C. The Characterization of Pheochromocytoma and Its Impact on Overall Survival in Multiple Endocrine Neoplasia Type 2. J Clin Endocrinol Metab 98(11):E1813-9, 2013. e-Pub 2013. PMID: 24030942.
Ayala-Ramirez M, Palmer JL, Hofmann MC, de la Cruz M, Moon BS, Waguespack SG, Habra MA, Jimenez C. Bone Metastases and Skeletal-Related Events in Patients with Malignant Pheochromocytoma and Sympathetic Paraganglioma. J Clin Endocrinol Metab 98(4):1492-7, 2013. e-Pub 2013. PMID: 23436918.
Morris LF, Waguespack SG, Edeiken-Monroe BS, Lee JE, Rich TA, Ying AK, Warneke CL, Evans DB, Perrier ND, Grubbs EG. Ultrasonography Should Not Guide the Timing of Thyroidectomy in Pediatric Patients Diagnosed with Multiple Endocrine Neoplasia Syndrome 2A through Genetic Screening. Ann Surg Oncol 20(1):53-9, 2013. e-Pub 2013. PMID: 22890595.
Habra MA, Ejaz S, Feng L, Das P, Deniz F, Grubbs EG, Phan A, Waguespack SG, Ayala-Ramirez M, Jimenez C, Perrier ND, Lee JE, Vassilopoulou-Sellin R. A Retrospective Cohort Analysis of the Efficacy of Adjuvant Radiotherapy After Primary Surgical Resection in Patients With Adrenocortical Carcinoma. J Clin Endocrinol Metab 98(1):192-7, 2013. e-Pub 2013. PMID: 23150683.
Carhill AA, Cabanillas ME, Jimenez C, Waguespack SG, Habra MA, Hu M, Ying A, Vassilopoulou-Sellin R, Gagel RF, Sherman SI, Busaidy NL. The Non-investigational Use of Tyrosine Kinase inhibitors in Thyroid Cancer: Establishing a Standard for Patient Safety and Monitoring. J Clin Endocrinol Metab 98(1):31-42, 2013. e-Pub 2013. PMID: 23185034.
Hightower E, Cabanillas ME, Fuller GN, McCutcheon IE, Hess KR, Shah K, Waguespack SG, Corley LJ, Devin JK. Phospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas. Pituitary 15(4):556-61, 2012. e-Pub 2012. PMID: 22120760.
Morris LF, Waguespack SG, Warneke CL, Ryu H, Ying AK, Anderson BJ, Sturgis EM, Clayman GL, Lee JE, Evans DB, Grubbs EG, Perrier ND. Long-Term Follow- Up Data May Help Manage Patient and Parent Expectations for Pediatric Patients Undergoing Thyroidectomy. Surgery 152(6):1165-71, 2012. e-Pub 2012. PMID: 23158186.
Ayala-Ramirez M, Chougnet CN, Habra MA, Palmer JL, Leboulleux S, Cabanillas ME, Caramella C, Anderson P, Al Ghuzlan A, Waguespack SG, Deandreis D, Baudin E, Jimenez C. Treatment with Sunitinib for Patients with Progressive Metastatic Pheochromocytomas and Sympathetic Paragangliomas (*article selected and evaluated by the Faculty of 1000). J Clin Endocrinol Metab 97(11):4040-50, 2012. e-Pub 2012. PMID: 22965939.
Ayala-Ramirez M, Feng L, Habra MA, Rich T, Dickson PV, Perrier N, Phan A, Waguespack SG, Patel S, Jimenez C. Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: Insights from the largest single-institutional experience. Cancer 118(11):2804-12, 2012. e-Pub 2012. PMID: 22006217.
Jonasch E, McCutcheon IE, Waguespack SG, Wen S, Davis DW, Smith LA, Tannir NM, Gombos DS, Fuller GN, Matin SF. Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease. Ann Oncol 22(12):2661-6, 2011. e-Pub 2011. PMID: 22105611.
Clayman GL, Agarwal G, Edeiken BS, Waguespack SG, Roberts DB, Sherman SI. Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma. Thyroid 21(12):1309-16, 2011. e-Pub 2011. PMID: 22136266.
Ejaz S, Vassilopoulou-Sellin R, Busaidy NL, Hu MI, Waguespack SG, Jimenez C, Ying AK, Cabanillas M, Abbara M, Habra MA. Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: The University of Texas MD Anderson Cancer Center Experience. Cancer 117(19):4381-9, 2011. e-Pub 2011. PMID: 21412758.
Khan MI, Habra MA, McCutcheon IE, Nogueras-González GM, Devin JK, Busaidy NL, Levine NB, Lindstrom W, Kagan D, Jimenez C, Waguespack SG. Random postoperative day 3 cortisol as a predictor of hypothalamic-pituitary-adrenal axis integrity after transsphenoidal surgery. Endocr Pract 17(5):1-25, 2011. e-Pub 2011. PMID: 21454228.
Khan MI, Waguespack SG, Habra MA, Broaddus R, Jimenez C. Acute-Onset Ectopic Adrenocorticotropic Hormone Syndrome Secondary to Metastatic Endometrioid Carcinoma of the Ovaries As a Fatal Complication. J Clin Oncol 29(16):e462-4, 2011. e-Pub 2011. PMID: 21422435.
Hong DS, Cabanillas ME, Wheler J, Naing A, Tsimberidou AM, Ye L, Waguespack SG, Hernandez M, El Naggar AK, Bidyasar S, Wright J, Sherman SI, Kurzrock R. Inhibition of the Ras/Raf/MEK/ERK and RET Kinase Pathways with the Combination of the Multikinase Inhibitor Sorafenib and the Farnesyltransferase Inhibitor Tipifarnib in Medullary and Differentiated Thyroid Malignancies. J Clin Endocrinol Metab 96(4):997-1005, 2011. e-Pub 2011. PMID: 21289252.
Ayala-Ramirez M, Feng L, Johnson MM, Ejaz S, Habra MA, Rich T, Busaidy N, Cote GJ, Perrier N, Phan A, Patel S, Waguespack SG, Jimenez C. Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators. J Clin Endocrinol Metab 96(3):717-25, 2011. e-Pub 2011. PMID: 21190975.
Jasim S, Ying AK, Waguespack SG, Rich TA, Grubbs EG, Jimenez C, Hu MI, Cote G, Habra MA. Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation. Thyroid 21(2):189-92, 2011. e-Pub 2011. PMID: 21186952.
Grubbs EG, Waguespack SG, Rich TA, Xing Y, Ying AK, Evans DB, Lee JE, Perrier ND. Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?. Surgery 148(6):1302-10, 2010. e-Pub 2010. PMID: 21134565.
Ayala-Ramirez M, Amir Habra M, Busaidy N, Cote G, Rich T, Waguespack SG, Jimenez C. A catecholamine crisis on Mount Kilimanjaro: a hypoxia effect?. J Travel Med 17(6):424-6, 2010. e-Pub 2010. PMID: 21050326.
Amhaz HH, Chamoun RB, Waguespack SG, Shah K, McCutcheon IE. Spontaneous involution of Rathke cleft cysts: is it rare or just underreported?. J Neurosurg 112(6):1327-32, 2010. e-Pub 2010. PMID: 19929199.
Cabanillas ME, Waguespack SG, Bronstein Y, Williams MD, Feng L, Hernandez M, Lopez A, Sherman SI, Busaidy NL. Treatment with Tyrosine Kinase Inhibitors for Patients with Differentiated Thyroid Cancer: the M. D. Anderson Experience. J Clin Endocrinol Metab 95(6):2588-95, 2010. e-Pub 2010. PMID: 20392874.
Clayman GL, Shellenberger TD, Ginsberg L, Edeiken B, El-Naggar AK, Sellin RV, Waguespack SG, Roberts DB, Sherman SI, Mirsha A. Approach and Safety of Comprehensive Central Compartment Dissection in Patients with Recurrent Papillary Thyroid Carcinoma. Head Neck 31(9):1152-63, 2009. e-Pub 2009. PMID: 19360746.
Waguespack SG, Williams MD, Clayman GL, Herzog CE. The Successful Use of Sorafenib to Treat Pediatric Papillary Thyroid Carcinoma. Thyroid 19(4):407-12, 2009. e-Pub 2009. PMID: 19355831.
Jimenez C, Cabanillas ME, Santarpia L, Jonasch E, Kyle KL, Lano EA, Matin SF, Nunez RF, Perrier ND, Phan A, Rich TA, Shah B, Williams MD, Waguespack SG. Use of the Tyrosine Kinase Inhibitor Sunitinib in a Patient with von Hippel-Lindau Disease: Targeting Angiogenic Factors in Pheochromocytoma and other von Hippel-Lindau Disease-related Tumors. J Clin Endocrinol Metab (*Cover Illustration) 94(2):386-91, 2009. e-Pub 2009. PMID: 19017755.
Bilen MA, Waguespack SG, Tannir NM, Pravinkumar SE, Tamboli P, Tu SM. Multisystem Crisis in a Patient with Presumptive Renal Cell Carcinoma. Clin Genitourin Cancer 6(2):128-30, 2008. e-Pub 2008. PMID: 18824438.
Rich TA, Jonasch E, Matin S, Waguespack SG, Gombos DS, Santarpia L, Stolle C, Jimenez C. A Novel von Hippel-Lindau Point Mutation Presents as Apparently Sporadic Pheochromocytoma. Cancer Invest 26(6):642-6, 2008. e-Pub 2008. PMID: 18584357.
Wray CJ, Rich TA, Waguespack SG, Lee JE, Perrier ND, Evans DB. Failure to recognize multiple endocrine neoplasia 2b: more common than we think?. Ann Surg Oncol 15(1):293-301, 2008. e-Pub 2008. PMID: 17963006.
McCutcheon IE, Waguespack SG, Fuller GN, Couldwell WT. Metastatic melanoma to the pituitary gland. Can J Neurol Sci 34(3):322-7, 2007. e-Pub 2007. PMID: 17803030.
Thompson MA, Habra MA, Routbort MJ, Holsinger FC, Perrier ND, Waguespack SG, Rodriguez MA. Primary adrenal natural killer/T-cell nasal type lymphoma: First case report in adults. Am J Hematol 82(4):299-303, 2007. e-Pub 2007. PMID: 17094095.
Shaw SA, Camacho LH, McCutcheon IE, Waguespack SG. Transient Hypophysitis after Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA4) Blockade. J Clin Endocrinol Metab 92(4):1201-2, 2007. e-Pub 2007. PMID: 17409339.
Waguespack SG, Hui SL, Dimeglio LA, Econs MJ. Autosomal Dominant Osteopetrosis: Clinical Severity and Natural History of 94 Subjects with a Chloride Channel 7 Gene Mutation. J Clin Endocrinol Metab 92(3):771-8, 2007. e-Pub 2007. PMID: 17164308.
Kouvaraki MA, Shapiro SE, Cote GJ, Lee JE, Yao JC, Waguespack SG, Gagel RF, Evans DB, Perrier ND. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World J Surg 30(5):643-53, 2006. e-Pub 2006. PMID: 16680581.
Chu K, Koller DL, Snyder R, Fishburn T, Lai D, Waguespack SG, Foroud T, Econs MJ. Analysis of variation in expression of autosomal dominant osteopetrosis type 2: searching for modifier genes. Bone 37(5):655-61, 2005. e-Pub 2005. PMID: 16120485.
Lora MS, Waguespack SG, Moley JF, Walvoord EC. Adrenal ganglioneuromas in children with multiple endocrine neoplasia type 2: a report of two cases. J Clin Endocrinol Metab 90(7):4383-7, 2005. e-Pub 2005. PMID: 15827098.
Habra MA, Feig BW, Waguespack SG. Image in endocrinology: adrenal pseudocyst. J Clin Endocrinol Metab 90(5):3067-8, 2005. e-Pub 2005. PMID: 15872337.
Cagle AP, Waguespack SG, Buckingham BA, Shankar RR, Dimeglio LA. Severe infantile hypercalcemia associated with Williams syndrome successfully treated with intravenously administered pamidronate. Pediatrics 114(4):1091-5, 2004. e-Pub 2004. PMID: 15466114.
Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, Asper JA, Diaz EM, Evans DB, Gagel RF, Garden A, Hoff AO, Lee JE, Morrison WH, Rosenthal DI, Sherman SI, Sturgis EM, Waguespack SG, Weber RS, Wirfel K, Vassilopoulou-Sellin R. Parathyroid carcinoma: a 22-year experience. Head Neck 26(8):716-26, 2004. e-Pub 2004. PMID: 15287039.
Alatalo SL, Ivaska KK, Waguespack SG, Econs MJ, Väänänen HK, Halleen JM. Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis). Clin Chem 50(5):883-90, 2004. e-Pub 2004. PMID: 15016726.
Yip L, Lee JE, Shapiro SE, Waguespack SG, Sherman SI, Hoff AO, Gagel RF, Arens JF, Evans DB. Surgical management of hereditary pheochromocytoma. J Am Coll Surg 198(4):525-34; discussion 534-5, 2004. e-Pub 2004. PMID: 15051000.
Alvarado F, Waguespack SG, Campbell JH, Williams TP. Expansile intraosseus lesion of the mandible. J Oral Maxillofac Surg 61(11):1318-23, 2003. e-Pub 2003. PMID: 14613089.
Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack SG, Gupta A, Hannon T, Econs MJ, Bianco P, Gehron Robey P. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112(5):683-92, 2003. e-Pub 2003. PMID: 12952917.
Waguespack SG, Koller DL, White KE, Fishburn T, Carn G, Buckwalter KA, Johnson M, Kocisko M, Evans WE, Foroud T, Econs MJ. Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II. J Bone Miner Res 18(8):1513-8, 2003. e-Pub 2003. PMID: 12929941.
Wilson JL, Sokol DK, Smith LH, Snook RJ, Waguespack SG, Kincaid JC. Acute painful neuropathy (insulin neuritis) in a boy following rapid glycemic control for type 1 diabetes mellitus. J Child Neurol 18(5):365-7, 2003. e-Pub 2003. PMID: 12822825.
Waguespack SG, Hui SL, White KE, Buckwalter KA, Econs MJ. Measurement of tartrate-resistant acid phosphatase and the brain isoenzyme of creatine kinase accurately diagnoses type II autosomal dominant osteopetrosis but does not identify gene carriers. J Clin Endocrinol Metab 87(5):2212-7, 2002. e-Pub 2002. PMID: 11994366.
Rolston KV, Elting L, Waguespack SG, Ho DH, LeBlanc B, Bodey GP. Survey of antibiotic susceptibility among gram-negative bacilli at a cancer center. Chemotherapy 42(5):348-53, 1996. e-Pub 1996. PMID: 8874974.

Invited Articles

Shariq OA, Waguespack SG, Hamidi S, Kensing BC, Hu MI, Skefos CM, Perrier ND. Approach to the Patient: Hereditary Medullary Thyroid Carcinoma. J Clin Endocrinol Metab 110(9):2685-2697, 2025. e-Pub 2025. PMID: 40105880.
Skefos CM, Waguespack SG, Perrier ND, Hu MI. CDC73-Related Disorders. In: Adam MP, Bick S, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026, 2023. e-Pub 2023. PMID: 20301744.
Lebbink CA, Waguespack SG, van Santen HM. Thyroid Dysfunction and Thyroid Cancer in Childhood Cancer Survivors: Prevalence, Surveillance and Management. Front Horm Res 54:1-14, 2021. e-Pub 2021. PMID: 33690237.
Hanafy AK, Mujtaba B, Roman-Colon AM, Elsayes KM, Harrison D, Ramani NS, Waguespack SG, Morani AC. Imaging features of adrenal gland masses in the pediatric population. Abdom Radiol (NY) 45(4):964-981, 2020. e-Pub 2020. PMID: 31538225.
Khan MI, Waguespack SG, Ahmed I. Recent advances in the management of hyponatremia in cancer patients. Journal of Cancer Metastasis and Treatment 5(71), 2019. e-Pub 2019.
Waguespack SG. Thyroid Sequelae of Pediatric Cancer Therapy. Horm Res Paediatr 91(2):1-14, 2019. e-Pub 2019. PMID: 30541010.
Hyde SM, Rich TA, Waguespack SG, Perrier ND, Hu MI. CDC73-Related Disorders. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. Source GeneReviews® [Internet], 2018. e-Pub 2018.
Cabanillas ME, Busaidy NL, Khan SA, Gunn GB, Dadu R, Rao SN, Waguespack SG. Molecular diagnostics and anaplastic thyroid carcinoma: the time has come to harvest the high hanging fruit. International Journal of Endocrine Oncology 3(3):221-233, 2016. e-Pub 2016.
Bauer AJ, Francis GL, Waguespack SG, Zimmerman D, Krishnan S, Breidbart E, Viswanathan P, McDonough RJ, Barger K, Yan Y, Yee JK, Bauman A, Jimenez-Vega J, Rose SR, Backeljauw PF, Newfield R. How Can We Apply The New American Thyroid Association Treatment Guidelines For Children And Adolescents With Thyroid Cancer To Improve Patient Management? Novel Insights Into Clinical Experience. US Endocrinology 12(1):39-51, 2016. e-Pub 2016.
Jackson MA, Rich TA, Hu MI, Perrier ND, Waguespack SG. CDC73-Related Disorders. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet], 2015. e-Pub 2015.
Tuttle RM, Haddad RI, Ball DW, Byrd D, Dickson P, Duh QY, Ehya H, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, Lydiatt WM, McCaffrey J, Moley JF, Parks L, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ, Hoffmann KG, Hughes M. Thyroid carcinoma, version 2.2014. J Natl Compr Canc Netw 12(12):1671-80; quiz 1680, 2014. e-Pub 2014. PMID: 25505208.
Kalkan E, Waguespack SG. Endocrine Tumors Associated with Neurofibromatosis Type 1, Peutz- Jeghers Syndrome and Other Familial Neoplasia Syndromes. Front Horm Res 41:166-181, 2013. e-Pub 2013. PMID: 23652677.
Waguespack SG, Rich TA, Perrier ND, Jimenez C, Cote GJ. Management of medullary thyroid carcinoma and MEN2 syndromes in childhood. (Selected as a Medscape CME article). Nat Rev Endocrinol 7(10):596-607, 2011. e-Pub 2011. PMID: 21862994.
Tuttle RM, Ball DW, Byrd D, Dilawari RA, Doherty GM, Duh QY, Ehya H, Farrar WB, Haddad RI, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey JC, Olson JA, Parks L, Ridge JA, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ. Thyroid Carcinoma. J Natl Compr Canc Netw 8(11):1228-1274, 2010. e-Pub 2010. PMID: 21081783.
Waguespack SG, Francis G. Initial Management and Follow-up of Differentiated Thyroid Cancer in Children. J Natl Compr Canc Netw 8(11):1289-1300, 2010. e-Pub 2010. PMID: 21081785.
Waguespack SG, Francis GL. Current Understanding and Treatment of Differentiated Thyroid Cancer in Children-A Review. US Endocrinology 6:84-91, 2010. e-Pub 2010.
Tuttle RM, Ball DW, Byrd D, Daniels GH, Dilawari RA, Doherty GM, Duh QY, Ehya H, Farrar WB, Haddad RI, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey J, Olson JA, Parks L, Ridge JA, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ. Medullary carcinoma. J Natl Compr Canc Netw 8(5):512-30, 2010. e-Pub 2010. PMID: 20495082.
Landry CS, Waguespack SG, Perrier ND. Surgical Management of non-Multiple Endocrine Neoplasia Endocrinopathies: State-of-the-Art Review. Surg Clin North Am 89(5):1069-89, 2009. e-Pub 2009. PMID: 19836485.
Ying AK, Huh W, Bottomley S, Evans DB, Waguespack SG. Thyroid cancer in young adults. Semin Oncol 36(3):258-74, 2009. e-Pub 2009. PMID: 19460583.
Rich TA, Hu MI, Martin JW, Perrier ND, Waguespack SG. CDC73-Related Disorders [Includes: CDC73-Related Familial Isolated Hyperparathyroidism, Hyperparathyroidism-Jaw Tumor Syndrome, CDC73-Related Parathyroid Carcinoma] [Last Update May 24, 2012]. In: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993-, 2008. e-Pub 2008.
Grubbs EG, Rich TA, Li G, Sturgis EM, Younes MN, Myers JN, Edeiken-Monroe B, Fornage BD, Monroe DP, Staerkel GA, Williams MD, Waguespack SG, Hu MI, Cote G, Gagel RF, Cohen J, Weber RS, Anaya DA, Holsinger FC, Perrier ND, Clayman GL, Evans DB. Recent advances in thyroid cancer. In brief. Curr Probl Surg 45(3):149-51, 2008. e-Pub 2008. PMID: 18346476.
Grubbs EG, Rich TA, Li G, Sturgis EM, Younes MN, Myers JN, Edeiken-Monroe B, Fornage BD, Monroe DP, Staerkel GA, Williams MD, Waguespack SG, Hu MI, Cote G, Gagel RF, Cohen J, Weber RS, Anaya DA, Holsinger FC, Perrier ND, Clayman GL, Evans DB. Recent advances in thyroid cancer. Curr Probl Surg 45(3):156-250, 2008. e-Pub 2008. PMID: 18346477.

Review Articles

Robertson IJ, Gregory TA, Waguespack SG, Penas-Prado M, Majd NK. Recent Therapeutic Advances in Pituitary Carcinoma. J Immunother Precis Oncol 6(2):74-83, 2023. e-Pub 2023. PMID: 37214211.
Waguespack SG. Beyond the "3 Ps": A critical appraisal of the non-endocrine manifestations of multiple endocrine neoplasia type 1. Front Endocrinol (Lausanne) 13:1029041, 2022. e-Pub 2022. PMID: 36325452.
Yalniz C, Morani AC, Waguespack SG, Elsayes KM. Imaging of Adrenal-Related Endocrine Disorders. Radiol Clin North Am 58(6):1099-1113, 2020. e-Pub 2020. PMID: 33040851.
Castinetti F, Moley J, Mulligan L, Waguespack SG. A comprehensive review on MEN 2B. Endocr Relat Cancer 25(2):T29-T39, 2018. e-Pub 2018. PMID: 28698189.
Wagner-Bartak NA, Baiomy A, Habra MA, Mukhi SV, Morani AC, Korivi BR, Waguespack SG, Elsayes KM. Cushing Syndrome: Diagnostic Workup and Imaging Features, With Clinical and Pathologic Correlation. AJR Am J Roentgenol 209(1):19-32, 2017. e-Pub 2017. PMID: 28639924.
Khan MI, Dellinger RP, Waguespack SG. Electrolyte Disturbances in Critically Ill Cancer Patients: An Endocrine Perspective. J Intensive Care Med 33(3):147-158, 2017. e-Pub 2017. PMID: 28535742.
Khan MI, Waguespack SG, Hu MI. Medical Management of Postsurgical Hypoparathyroidism. Endocr Pract 17 Suppl 1:1-19, 2011. e-Pub 2011. PMID: 21134871.
Francis G, Waguespack SG. An individualized approach to the child with thyroid cancer. Expert Rev Endocrinol Metab 6(1):85-92, 2011. e-Pub 2011. PMID: 30764038.
Stephen MD, Zage PE, Waguespack SG. Gonadotropin-Dependent Precocious Puberty: Neoplastic Causes and Endocrine Considerations. Int J Pediatr Endocrinol (*article selected and evaluated by the Faculty of 1000) 2011(Article ID 184502):184502, 2011. e-Pub 2011. PMID: 21603196.
Waguespack SG, Rich T, Grubbs E, Ying AK, Perrier ND, Ayala-Ramirez M, Jimenez C. A Current Review of the Etiology, Diagnosis, and Treatment of Pediatric Pheochromocytoma and Paraganglioma. J Clin Endocrinol Metab 95(5):2023-37, 2010. e-Pub 2010. PMID: 20215394.

Professional Educational Materials

Waguespack SG. Pediatric Endocrine Tumors: Hereditary Syndromes and Prospective Monitoring. Endocrine Society, 2019.
Waguespack SG. Differentiated Thyroid Cancer in Children. Endocrine Society, 2018.
Waguespack SG. "Gynecomastia and Klinefelter Syndrome." A section of an internet-based educational project entitled "A Pocket Rotation in Pediatric Endocrinology.". John Fuqua, ed, 2004.
Waguespack SG. Delayed puberty algorithm for the "Pocket Pediatric Manual.". Department of Pediatrics, Indiana University School of Medicine, 2001.

Editorials

Bauer A, Wasserman JD, Waguespack SG. Pediatric thyroid cancer Guidelines: challenges in stratifying care based on limited data. Eur Thyroid J 11(6), 2022. PMID: 36228306.
Grubbs EG, Halperin DM, Waguespack SG, Gagel RF. History of the multiple endocrine neoplasia workshops and overview of MEN2019. Endocr Relat Cancer 27(8):E1-E5, 2020. PMID: 32508314.
Jimenez C, Waguespack SG. Functional imaging for pheochromocytoma-paraganglioma: a step closer to understanding its place in clinical practice. Endocrine 50(1):6-8, 2015. PMID: 26113425.
Waguespack SG. A perspective from pediatric endocrinology on the hereditary medullary thyroid carcinoma syndromes. Thyroid 19(6):543-6, 2009. PMID: 19499985.
Rich TA, Waguespack SG, Evans DB. Premonitory symptoms preceding metastatic medullary thyroid cancer in multiple endocrine neoplasia type 2B: An exploratory analysis. Surgery 144(6):1052-3, 2008. PMID: 19041017.

Abstracts

Williams-Perez S, Sosa JA, Zafereo ME, Cabanillas ME, Brinkman AK, Waguespack SG, Alexander JD, Leal VB, Volk RJ, MI-N H, Grubbs, EG. Patient-centered development and dissemination of MTCEducate.org, an online educational aid for patients with a rare cancer. ASCO 2024 Annual Meeting, 2024. e-Pub 2024.
Cabanillas ME, Jiyeong Lin J, Brose MS, McDermott RS, Almubarak M, Bauman JR, Casanova M, Kummar S, Lee SH, Leyvraz S, Oh DY, Shen L, Neu N, Bernard-Gauthier V, Mussi CE, Hong DS, Drilon AE, Waguespack SG. Long-term efficacy and safety of larotrectinib (laro) in patients (pts) with TRK fusion thyroid carcinoma (TC). ASCO 2024 Annual Meeting, 2024. e-Pub 2024.
Yang AT, Segers B, H, States L, Mahajan P, Ketterl TG, Waguespack SG, Caradonio O, Behl S, Li Y, Zhuang G, Isaza A, Sisko L, Franco A, Bauer AJ, Laetsch, TW. Impact of molecular therapy on radioactive iodine uptake in patients with oncogenedriven metastatic differentiated thyroid cancer. ASCO 2024 Annual Meeting, 2024. e-Pub 2024.
Feldman HA, Silva-Figueroa, A, Halfteck G, Williams M, Busaidy NL, Waguespack SG, Graham P, Perrier, N. Atypical Parathyroid Neoplasm with Soft Tissue Extension: Is tis Accurate?. American Association of Endocrine Surgeons 44th Annual Meeting, Dallas, Texas, April 20-22, 2024, 2024. e-Pub 2024.
Dudzinski SO, Cabanillas ME, Busaidy NL, Hu MI, Dadu R, Gunn GB, Reddy J, Phan J, Beckham T, Waguespack SG, Sherman S, Ying AK, Gandhi C, Wang Z, Liao Z, Chang JY, Ludmir EB, Chen AB, Welsh JW, Ning MS. Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer. American Society for Radiation Oncology 65th Annual Meeting, San Diego, CA, October 1-3, 2023 117(2), 2023. e-Pub 2023.
Waguespack SG, Lin JJ, Brose MS, Almubarak M, Casanova M, Kummar S, Lee SH, Levyraz S, Oh DY, Shen L, Norenberg R, Bernard-Gauthier V, Mussi CE, Hong DS, Drilon A, Cabanillas ME. Long-Term Efficacy and Safety of Larotrectinib in Patients with Tropomyosin Receptor Kinase (TRK) Fusion Differentiated Thyroid Carcinoma (DTC). World Congress on Thyroid Cancer 2023, 2023. e-Pub 2023.
Yamashita TS, Al-Ward R, Xu G, Lu Y, Fisher S, Grubbs E, Perrier N, Waguespack SG, Varghese J, Habra MA, Jimenez C, Graham, P. Does disease debulking of metastatic Pheochromocytoma and Paranganglioma alter treatment with High-specific-activity Iodine 131 Metaiodobenzylguanidine?. The Journal of Nuclear Medicine, SNMMI Annual Meeting, Chicago, Illinois, June 24-27, 2023 64(1), 2023. e-Pub 2023.
Cabanillas ME, Lin JJ, Brose MS, McDermott RS, Almubarak M, Bauman JR, Casanova M, Kummar S, Lee SH, Levyraz S, Oh DY, Shen L, Norenberg R, Bernard-Gauthier V, Mussi CE, Hong DS, Drilon A, Waguespack SG. Larotrectinib (laro) long-term efficacy and safety in patients (pts) with tropomyosin receptor kinase (TRK) fusion thyroid carcinoma (TC). ASCO 2023 Annual Meeting, 2023. e-Pub 2023.
Brondani VB, Griffin AM, Owen TJ, Merriman KW, Varghese JM, Jimenez C, Waguespack SG, Graham PH, Campbell MT, Hassan MM, Habra MA. Changes in the Incidence and Geographical Distribution of Adrenocortical Carcinoma: A Retrospective Analysis of a State Cancer Registry. ENDO 2023 (Endocrine Society Annual Meeting), 2023. e-Pub 2023.
Castellanos LE, Zafereo ZE, Wang JR, Ying AK, Waguespack SG. Clinical Outcomes in Patients with Pediatric Papillary Thyroid Cancer not Treated with RAI (oral presentation). 2023 PES Annual Meeting, 2023. e-Pub 2023.
Hamidi S, Yedururi S, Hu MI, Zafereo ME, Jimenez C, Grubbs EG, Waguespack SG. Efficacy and Safety of Selective RET-inhibitors in Hereditary MTC: A Real-world Experience (oral presentation). World MEN Meeting 2023, 2023. e-Pub 2023.
Castellanos LE, Zafereo ME, Wang JR, Ying AK, and Waguespack SG. A Retrospective Analysis of Patients with Pediatric Papillary Thyroid Cancer not treated with RAI: Is Less More? (oral presentation). 2023 International Meeting of Pediatric Endocrinology, 2023. e-Pub 2023.
Lui MS, Fisher SB, Grubbs EG, Perrier ND, Waguespack SG, Varghese, J, Habra MA, Jimenez C, Graham PH. Post-Operative Biochemical Surveillance Thresholds Can be Used to Monitor for Sympathetic Pheochromocytoma/Paraganglioma Recurrence and Metastasis. NANETS 2022 Symposium, 2022. e-Pub 2022.
Shirali, A, Hu, M, Chiang YJ, Zafereo, M, Dadu R, Busaidy N, Cabanillas M, Waguespack SG, Sherman SI, Subbiah V, Graham P, Fisher S, Perrier N, Sosa J, Grubbs E. Next-Generation Sequencing in Sporadic Medullary Thyroid Cancer Patients: Evaluating the Relationship Between Somatic Alteration Profile and Disease Aggressiveness (oral presentation). 2022 Annual Meeting of the American Thyroid Association, 2022. e-Pub 2022.
Cabanillas, ME, Lin JJ, Brose MS, McDermott R, Almubarak M, Bauman, J, Casanova M, Krishnamurthy A, Kummar S, Lee SH, Leyvraz S, Oh DY, Shen L, Norenberg R, Dima L, Mussi CE, Hong DS, Drilon A, Waguespack SG. Updated Efficacy and Safety of Larotrectinib in Patients With Advanced Tropomyosin Receptor Kinase (TRK) Fusion-Positive Thyroid Carcinoma. 2022 Annual Meeting of the American Thyroid Association, 2022. e-Pub 2022.
Vodopivec DM, Cabanillas ME, Busaidy NL, Gule-Monroe MK, Zafereo ME, Wang JR, Williams MD, Waguespack SG, Basset R, Maniakas A, Lai SY, Dadu R. Single Center Experience with the Combination of Lenvatinib and Pembrolizumab for the Treatment of Anaplastic Thyroid Cancer. ENDO 2022 (Endocrine Society Annual Meeting), 2022. e-Pub 2022.
Al-Ward R, Balderrama Brondani V, Sawani S, Basset R, Xu G, Waguespack SG, Varghese J, Lu Y, Habra MA, Jimenez C. High-Specific-Activity Iodine I3I Metaiodobenzylguanidine for the Treatment of Advanced Pheochromocytoma and Paraganglioma: A Real-World Study. ENDO 2022 (Endocrine Society Annual Meeting), 2022. e-Pub 2022.
Contrera KJ, Gule-Monroe MK, Cabanillas ME, Hu MI, Busaidy NL, Dadu R, Waguespack SG, Wang J, Myers J, Grubbs EG, Subbiah V, Williams MD, Zafereo ME. Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series. AHNS Annual Meeting at COSM 2022, 2022. e-Pub 2022.
Clemente-Gutierrez U, Pieterman CRC, Erstad DJ, Lui MS, Huang BL, Shirali AS, Fisher SB, Graham PH, Grubbs EG, Waguespack SG, Ng CS, Perrier N. Beyond the 3 P's: Adrenal Involvement in MEN1. Society of Surgical Oncology SSO 2022 - International Conference on Surgical Cancer Care, 2022. e-Pub 2022.
Waguespack SG, Drilon A, Lin JJ, Brose MS, McDermott R, Almubarak M, Bauman J, Casanova M, Kummar S, Levyraz S, Oh DY, Park K, Sohal D, NOrenberg R, SilvertownJ, Brega N, Hong DS, Cabanillas ME. Long-term Efficacy and Safety of Larotrectinib in Patients with Advanced TRK Fusion-positive Thyroid Carcinoma. 90th Annual Meeting of the American Thyroid Association, 2021. e-Pub 2021.
Maniakas A, Sullivan AT, Busaidy NL, Cabanillas ME, Dadu R, Fisher SB, Graham PH, Gross ND, Grubbs EG, Gunn GB, Hu MI, Li X, Perrier ND, Waguespack SG, Wang JR, Williams MD, Zafereo ME. Decreasing Indications for Postoperative Adjuvant Radiation Therapy in Locoregionally-Advanced Medullary Thyroid Cancer. 90th Annual Meeting of the American Thyroid Association, 2021. e-Pub 2021.
Aldehaim M, Phan J, Waguespack S, Wang X, Lim TY, Roberts D, Hanna E, Su SY. Pituitary Hormone Dysfunction following Radiotherapy for Sinonasal and Nasopharyngeal Cancers. AHNS 10th International Conference on Head & Neck Cancer, 2021. e-Pub 2021.
Banik GL, Shindo ML, Kraimer KL, Manzione K, Reddy A, Kazahaya K, Bauer AJ, Rastatter JC, Zafereo ME, Waguespack SG, Chelius DC, Quintanilla-Dieck L. Prevalence and Risk Factors for Multifocality in Pediatric Thyroid Cancer: A Multicenter Study. AHNS 10th International Conference on Head & Neck Cancer, 2021. e-Pub 2021.
Wirth LJ, Hu MI, Waguespack SG, Dosiou C, Ladenson P, Livhits MJ, Sadow PM, Krane J, Stack BC, Zafereo M, Ali SZ, Weitzman SP, Hao Y, Babiarz J, Kennedy G, Kloos R. NTRK, RET, BRAF, and ALK fusions in thyroid fine-needle aspirates (FNAs). J Clin Oncol (2021 ASCO Annual Meeting) 39(Suppl 15):abstr 6083, 2021. e-Pub 2021.
Maid N, Waguespack SG, Filip J, Fu S, Penas-Prado M, Xu M, Alshawa A, Kamiya-Matsuoka C, Raza S, McCutcheon I, Aung N. Efficacy of Pembrolizumab in Patients with Pituitary Carcinoma: Results from a Phase II Study. Neuro-Oncology 22(Suppl 2):ii39-40, 2020. e-Pub 2020.
Cabanillas ME, Drilon A, Farago AF, Brose MS, McDermott R, Sohol D, Oh D, Almubarak M, Bauman J, Chu E, Kummar S, Leyvraz S, Park K, Reeves JA, Dina L, Maeda P, Rodrigues L, Brega N, Hong DS, Waguespack SG. Larotrectinib treatment of advanced TRK fusion thyroid cancer. Annals of Oncology 31(Suppl 4):S1086, 2020. e-Pub 2020.
Brown, S, Gruschkus SK, Waguespack SG, Dadu R, Zafereo M, Cabanillas ME, Grubbs EG, Sherman SI, Hu MI. RAS-mutated sporadic medullary thyroid cancer: A single-center experience. Journal Clinical Oncology, 2020. e-Pub 2020.
Livhits MJ, Hu MI, Waguespack SG, Wirth LJ, Ladenson PW, Stack BC, Hao Y, Babiarz JE, Kennedy GC, Kloos RT. Positive Predictive Value of TP53 Variants in Bethesda III/IV Thyroid Fine-Needle Aspirates. Journal of the Endocrine Society 4(Suppl 1):A1099, 2020. e-Pub 2020.
Gammons S, Hu MI, Zafereo ME, Busaidy NL, Perrier ND, Bassett RL, Hyde SM, Grubbs EG, Waguespack SG. Sporadic MTC in Children: Characterization of a Rare Disease. Journal of the Endocrine Society 4(Suppl 1):A1058, 2020. e-Pub 2020.
Fazeli S, Dadu R, Waguespack SG, MD, Sherman SI, Busaidy NL, Hu MI, Jimenez C, Habra MA, MD, Williams M, Altameemi L, Poropatich K, Routbort MJ, Luthra R, Patel KP, Cabanillas M. TRK-Fusion Thyroid Cancer: A Clinical Overview in a Large Population at a Single Cancer Center. Journal of the Endocrine Society 4(Suppl 1):A165-A166, 2020. e-Pub 2020.
Waguespack SG, Drilon A, Farago AF, Sohal D, Oh DY, Ma P, McDermott R, Nanda S, Kummar S, Lee J, Ku N, Cox M, Childs B, Hong D, Cabanillas ME. Treatment of Advanced TRK Fusion Thyroid Cancer with Larotrectinib. 42nd Annual Meeting of the European Thyroid Association, 2019. e-Pub 2019.
Falcone R, Waguespack SG, Dadu R, Sherman SI, Busaidy NL, Hu MI, Jimenez C, Weitzman S, Cabanillas ME. Redifferentiation Radioiodine (RAI)-Therapy in Patients (PTS) with Metastatic Papillary, Follicular and Poorly Differentiated Thyroid Cancer (TC). Thyroid 29(s1), 2019. e-Pub 2019.
Brown S, Waguespack SG, Chuang H, Murphy W, Hu MI. Radiologic Response by Gallium Dotatate PET/CT in Patients with Medullary Thyroid Carcinoma on Systemic Therapy. Thyroid 29(s1), 2019. e-Pub 2019.
Fazeli S, Gule-Monroe MK, Cabanillas ME, Busaidy NL, Waguespack SG, Hu MI, Jimenez C, Sherman SI, Habra MA, Cote GJ, Hoffman M, Basset R, Dadu R. Response to BRAF With/Without MEK Inhibitors in BRAFV600E Plus TERT Promoter Mutated Differentiated Thyroid Cancers (DTC). Thyroid 29(s1), 2019. e-Pub 2019.
Hu MI, Cote GJ, Hai T, Busaidy NL, Cabanillas ME, Dadu R, Gagel RF, Grubbs EG, Habra MA, Jimenez C, Subbiah V, Waguespack SG, Williams MD, Zafereo ME, Sherman SI. Emergence of Resistance-Associated Mutations of RET V804M and KRAS in Medullary Thyroid Carcinoma (MTC) Patients Treated with Tyrosine Kinase Inhibitors (TKI) Cabozantinib and Vandetanib. Thyroid 29(s1), 2019. e-Pub 2019.
Wu SY, Chiang YJ, Sturgis EM, Zafereo ME, Grubbs EG, Lee JE, Waguespack SG, Perrier ND. Pediatric Risks of Hypoparathyroidism Following Total Thyroidectomy for Thyroid Cancer: A 21-year Tertiary Care Center Experience. 48th World Congress of Surgery (WCS), 2019. e-Pub 2019.
Wirth LJ, Waguespack SG, Busaidy NL, Hu MI, Grubbs EG, Weitzman SP, Zafereo M, Babiarz J, Hao Y, Huang J, Kennedy G, Walsh PS, Kloos R. Genomic landscape of FNAs positive for medullary thyroid cancer (MTC) and potential impact on systemic therapy. 2019 ASCO Annual Meeting, 2019. e-Pub 2019.
Agosto Salgado S, Waguespack SG, Cote, G, et al. Brain Metastases in Thyroid Cancer: Molecular Profile and Institutional Experience of a Single Tertiary Referral Center in the Era of Kinase Inhibitor Therapy. Journal of the Endocrine Society 3(Supplemental 1), 2019. e-Pub 2019.
Waguespack SG, Busaidy NL, Hu MI, et al. The Genomic Landscape of Preoperative FNAs Positive for the Afirma GSC Medullary Thyroid Cancer Classifier. Journal of the Endocrine Society 3(Supplement 1), 2019. e-Pub 2019.
Yedururi S, Cox VL, Kang HC, Marcal LP, Kaur H, Waguespack SG, Lee JE, Loyer EM. Updates in Diagnosis, Management and Treatment of Multiple Endocrine Neoplasia Type 1. RSNA 2018 Annual Meeting, 2018. e-Pub 2018.
Zagzag J, Nobecourt P, Zafereo M, Sturgis E, Waguespack SG, Williams M, Grubbs E, Perrier ND, Lee JE, Graham P. Minimally Invasive Follicular Thyroid Cancer Can Recur and Lead to Disease Specific Mortality. 88th Annual Meeting of the American Thyroid Association, Washington, DC, October 3-7, 2018, 2018. e-Pub 2018.
Dadu R, Cabanillas ME, de Groot P, Chang JY, Tang C, Sherman SI, Busaidy N, Waguespack SG, Hu M, Ying A, Habra M, Menon H, Welsh J. Ipilimumab with Stereotactic Ablative Radiation Therapy (SABR): Results of a Thyroid Cancer Expansion Cohort (Poster 65). 88th Annual Meeting of the American Thyroid Association, Washington, DC, October 3-7, 2018, 2018. e-Pub 2018.
Brose MS, Albert CM, Waguespack SG, Cabanillas ME, Ma PC, Sohal DP, Cox MC, Ku NC, Wirth L. Activity of Larotrectinib in Patients with Advanced TRK Fusion Thyroid Cancer (Oral presentation). 88th Annual Meeting of the American Thyroid Association, Washington, DC, October 3-7, 2018, 2018. e-Pub 2018.
Wu SY, C YJ, Fisher SB, Zafereo ME, Nguyen S, Arenas MA, Grubbs EG, Graham PH, Lee JE, Waguespack SG, Perrier ND. Risk Factors for Hypoparathyroidism Following Total Thyroidectomy in Children: a 21-year Experience in a High-Volume Cancer Center. The World Congress of Surgery, 2018. e-Pub 2018.
Simmons G, Nguyen H, Kaya D, Ahmed S, Dadu R, Cabanillas ME, Waguespack SG, Shah K. Imaging Findings of Cancer Immunotherapy Induced Hypophysitis, an Update. American Society of Neuroradiology 56th Annual Meeting, Vancouver, BC, Canada, June 2-7, 2018, 2018. e-Pub 2018.
Fisher SB, Cote G, Bui-Griffith J, Lu W, Tang X, Ha T, Williams M, Wistuba II, Waguespack SG, Fisher KE, Dorman C, Ludwig M, Graham P, Perrier N, Lee JE, Grubbs EG. Genetic Characterization of Childhood Survivors of the Chernobyl Accident with Medullary Thyroid Cancer. American Association of Endocrine Surgeons 39th Annual Meeting, Durham, North Carolina, May 6-8, 2018, 2018. e-Pub 2018.
Jimenez J, Tamsen G, Patel B, Pool M, Busaidy N, Waguespack SG, Habra M, Zhou S. A Phase 2 Study to Evaluate the Effects of Cabozantinib in Patients with Unresectable Metastatic Pheochromocytomas and Paragangliomas. Endocrine Practice (2018 AACE Annual Scientific & Clinical Congress Abstracts) 24(Supplement 1), 2018. e-Pub 2018.
Nguyen H, Ying AK, Hyde S, Cote GJ, Euscher E, Meyer L, Jonasch E, Waguespack SG. Von Hippel-Lindau Disease And Steroid Cell Tumor Of The Ovary: A New Association?. Endocrine Society's 100th Annual Meeting & Expo, Chicago, IL; March 17-20, 2018, 2018. e-Pub 2018.

Book Chapters

Pieterman, CR, Waguespack, SG. Multiple endocrine neoplasia syndromes and somatotroph adenomas, 173-195, 2021.
Pieterman CRC, Waguespack SG. Multiple endocrine neoplasia syndromes and somatotroph adenomas. In: Gigantism and Acromegaly. 1st. Academic Press (Elsevier), 173-195, 2021.
Arango ML, Waguespack SG. A Child with Papillary Thyroid Cancer and Metastatic Pulmonary Disease: Role of Radioactive Iodine Therapy. In: Thyroid Cancer: A Case-Based Approach. 2nd. Springer Nature, 209-219, 2021.
Bottomley SJ, Waguespack SG. An Adolescent with Papillary Thyroid Cancer and Locally Metastatic Disease but No Distant Metastasis. In: Thyroid Cancer: A Case-Based Approach. 2nd. Springer Nature, 93-102, 2021.
Mostoufi-Moab S, Venkattramani R, Bauer AJ, Waguespack SG. Chapter 30 Endocrine Tumors. In: Pizzo and Poplack's Principles and Practice of Pediatric Oncology. 8th. Wolters Kluwer, 811-841, 2020.
Waguespack SG, Fishbein L. Pheochromocytoma/Paraganglioma, Medullary Thyroid Carcinoma, and Hereditary Endocrine Neoplasia Syndromes. In: Sperling Pediatric Endocrinology. 5th. Elsevier, 491-527, 2020.
Waguespack SG. Rare Tumors: Thyroid Tumors, Adrenal Tumors. In: Nelson Textbook of Pediatrics. 21st. Elsevier, Inc, 2019.
Lee M, Waguespack SG, Graham PH, Hu MI, Zafereo ME. Syndromic Medullary Thyroid Carcinoma: MEN 2A and MEN 2B. In: Surgical and Medical Management of Diseases of the Thyroid and Parathyroid. 1st. Plural Publishing Inc, 2019.
Bauer AJ, Waguespack SG, Grover A, Francis GL. Thyroid Neoplasia. In: Pediatric Endocrinology A Practical Clinical Guide. 3rd. Springer, 439-476, 2018.
Waguespack SG, Chemaitilly W. Endocrine Sequelae of Central Nervous System Irradiation. In: Radiation Oncology for Pediatric CNS Tumors. 1st. Springer International Publishing, 537-551, 2018.
Waguespack SG, Wasserman JD. Pediatric Differentiated Thyroid Carcinoma. In: Practical Management of Thyroid Cancer. 2nd. Springer International Publishing, 273-294, 2018.
Livolsi V, DeLellis R, Komminoth P, Mete O, Muligan L, Schmid KW, Waguespack SG, Elisei R, Eng C. Multiple Endocrine Neoplasia Type 2. In: World Health Organization Classification of Tumours of Endocrine Organs. 4th. International Agency for Research on Cancer, 248-252, 2017.
Grubbs EG, Waguespack SG. Inherited Medullary Thyroid Carcinoma: Indications and Technique of Early Thyroidectomy. In: Medullary Thyroid Cancer. 1st. Springer International Publishing, 85-94, 2016.
Waguespack SG, Francis GL. Radionuclide Imaging and Treatment of Children with Thyroid Cancer. In: Thyroid Cancer: A Comprehensive Guide to Clinical Management. 3rd. Springer, 475-85, 2016.
Waguespack SG, Bauer AJ. Follicular Thyroid Cancer: Special Aspects in Children and Adolescents. In: Thyroid Cancer: A Comprehensive Guide to Clinical Management. 3rd. Springer, 801-05, 2016.
Bottomley SJ, Waguespack SG. A Child with Papillary Thyroid Cancer and Locally Advanced Disease but No Distant Metastasis. In: Thyroid Cancer: A Case-Based Approach. 1st. Springer, 111-118, 2016.
Arango ML, Waguespack SG. A Young Child with Papillary Thyroid Cancer and Metastatic Pulmonary Disease: Role of Radioactive Iodine Therapy in Children. In: Thyroid Cancer: A Case-Based Approach. 1st. Springer, 229-236, 2016.
Waguespack SG, Huh W, Bauer AJ. Chapter 36 Endocrine Tumors. In: Principles and Practice of Pediatric Oncology. 7th. Wolters Kluwer, 919-945, 2015.
Waguespack SG. Chapter 506.1 Thyroid Tumors, Chapter 506.5 Adrenal Tumors. In: Nelson Textbook of Pediatrics. 20th. Elsevier, Inc, 2015.
Waguespack SG, Ying AK. Pheochromocytoma and Multiple Endocrine Neoplasia Syndromes. In: Pediatric Endocrinology. 4th. Elsevier, 533-568, 2014.
Waguespack SG, Grubbs EG, Hu MI. Multiple Endocrine Neoplasia Type 2. In: Clinical Genomics: Practical Applications in Adult Patient Care. 1st. McGraw Hill Education, 278-283, 2014.
Bauer AJ, Dinauer CA, Waguespack SG, Francis GL. Differentiated Thyroid Cancer in Children. In: Clinical Management of Thyroid Cancer. 1st. Future Medicine Ltd, 107-118, 2013.
Bauer AJ, Waguespack SG, Grover A, Francis GL. Thyroid Neoplasia. In: Pediatric Endocrinology: A Practical Clinical Guide. 2nd. Humana Press, 319-338, 2013.
Waguespack SG. Chapter 500 Rare Tumors (Thyroid Tumors and Adrenal Tumors). In: Nelson Textbook of Pediatrics. 19th. Elsevier Saunders, 1772-73, 2011.
Waguespack SG, Bauer AJ, Huh W, Ying AK. Chapter 36 Endocrine Tumors. In: Principles and Practices of Pediatric Oncology. 6th. Lippincott Williams & Wilkins, 1068-97, 2010.
Waguespack SG, Wells SA. Thyroid Carcinoma. In: Cancer in Adolescents and Young Adults. Springer Verlag, 259-68, 2007.
Waguespack SG, Wells S, Ross J, Bleyer A. Thyroid Cancer. In: Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000. National Cancer Institute, NIH Pub No 06-5767, 143-54, 2006.
Waguespack SG, Maldonado M, Sekhar R, Gagel R, Balasubramanyam A. Endocrine Evaluation and Management of the Perioperative Cancer Patient. In: Acute Care of the Cancer Patient. Taylor & Francis, 43-67, 2005.
Waguespack SG, Pescovitz OH. Delayed Puberty. In: Developmental Endocrinology: From Research to Clinical Practice. 1st. Humana Press, 331-355, 2002.
Waguespack SG, Walvoord E, Pescovitz OH. Precocious and Delayed Puberty. In: Principles and Practice of Endocrinology and Metabolism. 3rd. Lippincott Williams & Wilkins, 893-908, 2001.
Waguespack SG, Castellanos LE. Hereditary Endocrine Neoplasia Syndromes. In: Sperling Pediatric Endocrinology, 6th edition. Elsevier.
Waguespack SG, Fishbein L. Pheochromocytoma and Paraganglioma. In: Sperling Pediatric Endocrinology, 6th edition. Elsevier.
Castellanos LE, Grubbs EG, Waguespack SG. Multiple Endocrine Neoplasia Type 2. In: Shifrin: Hereditary Endocrine Syndromes, 1e. Elsevier.

Letters to the Editor

Al Ward R, Waguespack SG, Varghese J, Lu Y, Jimenez C. Reply to the Letter to the Editor Concerning Metabolic and Pharmacological Interactions of 131I-MIBG. Clin Nucl Med 50: 1106-1107, 2024.
Sarvestani AL, Lambdin J, Hu M, Cabanillas M, Waguespack SG, Hernandez JM, Zafereo ME. Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancers. Ann Surg Oncol 31: 2202-2203, 2024.
Waguespack SG, Bauer AJ, Francis GL, Vassilopoulou-Sellin R. Radioactive Iodine for Pediatric Differentiated Thyroid Carcinoma: Sometimes "Less is More". J Clin Endocrinol Metab, 2011.
Waguespack SG, Rich TA. Multiple endocrine neoplasia syndrome type 2B in early childhood: long-term benefit of prophylactic thyroidectomy. Cancer 116: 2284, 2010.
White KE, Waguespack SG, Econs MJ. Case 29-2001: oncogenic hypophosphatemic osteomalacia. N Engl J Med 346: 381-2, 2002.